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ABSTRACT 
The effects different prebiotics, organic acid salts and an essential oil blend have 
on the bacterial community of biofloc particles (formed of bacteria, leftover feed, and 
feces) and shrimp gills tissue, hepatopancreas and intestinal contents, as well as on total 
hemocyte count (THC), were determined for the Pacific white shrimp, Litopenaeus 
vannamei. 
Shrimp were stocked in research tanks with a capacity to hold 41-L of artificial 28 
g/L salinity. Final weight, weight gain and survival were determined based on 
termination data. Also, biofloc and shrimp muscle samples were collected to determine 
ash, protein and lipid composition. In addition, denaturing gradient gel electrophoresis of 
biofloc and shrimp hepatopancreas, gills and intestine was conducted. 
For Trial I, prebiotics, fructooligosaccharide, galactooligosaccharide, mannan-
oligosaccharide and inulin, as well as non-prebiotic carbohydrates, wheat starch and 
sucrose, were added directly to the water. For Trial II, the same additives of Trial I and an 
essential oil blend were included in the feed with a 3% dietary inclusion level. For Trial 
III, four diets were prepared with fructooligosaccharide and galactooligosaccharide at 1.5 
and 3.0% dietary inclusion level each. Also, 6 diets were prepared with sodium acetate, 
sodium lactate and sodium propionate each at 0.75 and 1.5% dietary inclusion levels and 
a control diet with no additive inclusion. 
For the present experimental conditions, it can be concluded that the evaluated 
additives have a significant effect on the bacterial communities of the biofloc and those 
present in shrimp gills, hepatopancreas and intestinal contents when added to the water or 
iii 
feed. Significant increase in the THC was observed when the essential oil blend and the 
organic acid salts were included in feed of Trials II and III. Also, significant effects on 
water quality and biofloc levels were observed only when wheat starch was added to the 
culture water. 
The effects of feed and water additives on the bacterial populations of biofloc and 
shrimp gills, hepatopancreas and intestinal contents as well as on THC of shrimp when 
cultured in a biofloc technology system is a significant contribution to knowledge and to 
the shrimp aquaculture industry. 
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CHAPTER I 
INTRODUCTION 
 
I.1 Shrimp aquaculture 
Shrimp is the largest single aquaculture commodity in terms of value, accounting 
for about 14% of the total value of aquaculture products in 2014 (FAO, 2016; Robalino et 
al., 2016). According to FAO (2016), there was a global production by aquaculture of 
4,679,368 tons of shrimp in 2014 with a value of US$ 24,022,856,000 among which 
2,209 tons of shrimp were produced in the USA with a value of US$ 10,316,000. 
Traditionally, shrimp have been commercially farmed in earthen ponds using 
large land areas that are also highly demanded for other purposes like agriculture, 
wetland conservation, residential, industrial, and tourism activities. Shrimp harvested 
from commercial shrimp aquaculture contribute more than 55% of the world’s total 
supply, among which Pacific white shrimp Litopenaeus vannamei was responsible for 
about 76% of the total global shrimp yield in 2011 (Yu et al., 2014). However, in recent 
years, severe economic losses in the shrimp aquaculture industry have resulted from 
reduced production due to diseases caused by viruses such as the White Spot Syndrome 
Virus (WSSV) and the Taura Syndrome Virus (TSV), or bacterial outbreaks caused 
mainly by pathogenic Vibrio species (Tsai et al., 2014; Thitamadee et al., 2016). Most 
diseases generally occur as a result of stress and environmental deterioration in 
association with the intensification of shrimp farming (Tseng and Chen, 2004). Also, 
traditional shrimp farming practices in outdoor ponds with high water exchange have 
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caused environmental degradation and significant crop losses due to disease outbreaks 
(Cohen et al., 2005; Balcázar et al., 2007; Samocha et al., 2007; Ekasari et al., 2014). 
In order to reduce or eliminate water exchange, systems, such as the Biofloc 
Technology (BFT) system, have been developed in which water quality is controlled 
without the need to replace the existing water in the system with fresh or seawater. BFT 
is a system that facilitates intensive cultures and keeps investment and ongoing 
maintenance costs low as well as incorporating the potential to recycle feed nutrients 
(Avnimelech, 2012). Due to these advantages, BFT has gained attention in recent years as 
a desired system for commercial shrimp production. 
 
I.2 Biofloc Technology Systems: An Overview 
Biofloc technology (BFT) was initially developed in the early 1970s at Ifremer-
COP, French Polynesia (Emerenciano et al., 2013). Presently, the BFT culture system has 
become an emerging option for the development of eco-sustainable aquaculture (Dantas 
et al., 2016). BFT is an aquaculture strategy applied to a variety of system types and is 
currently most commonly used for the culture of shrimp and tilapia (Avnimelech, 2012). 
When using BFT as the culture strategy, cultured animals need be stocked in tanks or 
ponds at a high density and water exchange needs to be restricted for the large amount of 
nutrients from feeds that enters the water and accumulates in the system, contributing to 
the proliferation of a community of microorganisms including bacteria, algae, protists, 
and zooplankton (AES, 2016). A significant portion of these organisms are contained on 
and within biofloc particles which can reach a diameter of up to a few millimeters. 
Biofloc particles are primarily made up of microorganisms, feces, detritus, and 
3 
exopolymeric substances. The latter is a complex mixture of biopolymers comprising 
polysaccharides, proteins, nucleic acids, uronic acids, humic substances, lipids, etc., 
resulting from bacterial secretions, shedding of cell surface materials, cell lysates and/or 
adsorption of organic constituents (Pal and Paul, 2008). The microorganisms present in 
BFT systems create a nutrient recycling system, which reduces feed costs and improves 
water quality and shrimp immunity (AES, 2016). The different beneficial effects of using 
BFT as a shrimp culture strategy and the use of additives to enhance BFT as a food 
source, to enhance shrimp immunity and to control water quality have been documented 
(Avnimelech, 2012; Cardona et al., 2016; Ray et al., 2017; Xu et al., 2013; Xu and Pan, 
2014a). 
The recycling of feed nutrients carried out by bacteria present in biofloc makes it 
a valuable food source, contributing to the reduction in production costs (Tacon et al., 
2002; Wasielesky et al., 2006; Crab et al., 2010). Studies have confirmed that biofloc can 
be rich in proteins, vitamins and minerals, and can also provide amino acids (Tacon et al., 
2002; Kuhn et al., 2009, 2010; Crab et al., 2010). A bacterial community change 
represents a challenge to the operation of BFT systems because no information can be 
found in the literature concerning changes in bacterial communities that may promote 
more nutritious biofloc for shrimp, and how the bacterial community of biofloc particles 
is related to shrimp gills, hepatopancreas and intestinal bacteria flora. Furthermore, Crab 
et al. (2012) stated that optimization of the nutritional quality of biofloc is a challenge for 
further research. 
Biofloc technology is considered a practical solution to maintain water quality at 
optimum levels because this culture system is based on the capacity of autotrophic and 
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heterotrophic bacteria to utilize the nitrogen present in the water and convert it into new 
bacterial biomass (Avnimelech, 2009; De Schryver et al., 2008). The limited or zero-
water exchange of intensive biofloc shrimp production systems allows for accumulation 
of inorganic nitrogen, which is controlled via nitrification by chemoautotrophic bacteria 
(which in this dissertation will be called autotrophic phase) or assimilation by 
heterotrophic bacteria (which in this dissertation will be called heterotrophic phase). 
Both, nitrification and accumulation of inorganic carbon, occur simultaneously, but levels 
of intensity depend on extent of respective bacterial populations. 
Nitrification will increase in the presence of high culture densities of 
chemoautotrophic bacteria. Autotrophic nitrification is a two-step process in which 
ammonia is biologically oxidized into nitrite (catalyzed by ammonia-oxidizing bacteria 
such as Nitrosomonas spp. and Nitrosococcus spp.) and then to nitrate (catalyzed by 
nitrite-oxidizing bacteria such as Nitrobacter spp. and Nitrospira spp.) with oxygen as 
terminal electron acceptor (Rittman and McCarty, 2001). This process reduces alkalinity 
in the form of carbonates and bicarbonates (Chen and Blancheton, 2006). 
In order for the heterotrophic bacteria to utilize organic and inorganic nitrogen in 
the culture water, it is necessary to control the carbon:nitrogen ratio by reducing the feed 
protein content and/or by the addition of carbon into the culture water (De Schyver et al., 
2008). Uptake of carbon-based substrates and immobilization of nitrogen increase as 
levels of heterotrophic bacteria also increase. 
The close relationship between bacteria present in BFT and water quality makes 
bacterial community changes an important area of study due to their potential effect on 
water quality.  
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One of the downsides of the BFT system is that biofloc is a dynamic growth 
medium, which potentially results in an increase in populations of pathogenic bacterial 
species (mainly Vibrio spp.) because of high concentrations of organic matter in the 
culture water (Ferreira et al., 2011). Increases in potential pathogen populations may 
result in reduced shrimp production due to impaired survival and/or growth rate.  
Application of antibiotics in aquaculture for prophylactic and therapeutic 
purposes has been criticized due to the potential development of antibiotic-resistant 
bacteria, the presence of antibiotic residues in seafood, undesired modification of the 
bacterial population in the aquatic environment and suppression of the animal’s immune 
system (Ng et al., 2009). For those reasons, alternatives to antibiotics that improve 
shrimp immune defense and resistance to pathogens as well as improving growth and 
survival are desired. Targeted modifications of bacterial populations in the 
gastrointestinal tract of shrimp have been suggested as alternatives to antibiotics that may 
hold the key to optimize weight gain and improve health status of farmed animals (Anuta 
et al., 2016). Such targeted modifications of bacterial populations could be achieved with 
the use of different additives as reviewed by Anuta et al. (2016). 
It is widely known that microorganisms, their cellular components or their 
metabolites may act as immunostimulants to enhance the shrimp’s innate immune system 
and provide improved protection against pathogens (Smith et al., 2003; Vazquez et al., 
2009). However, very few studies (de Jesús Becerra-Dorame et al., 2014; Xu and Pan, 
2013, 2014b; Kim et al., 2014) have investigated the immunological potential of 
microorganisms found in BFT. Furthermore, there were no studies found in the literature 
that evaluated the effect of different compounds with potential effect on bacterial flora of 
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biofloc and shrimp gills, hepatopancreas and intestinal contents and on shrimp production 
and health. 
 
I.3 Additives 
A few additives have been studied with the aim to improve water quality and 
health and growth of the animals when cultured under BFT conditions. Antibiotics and 
disinfectants are additives commonly used in aquaculture to counter disease outbreaks, 
however, they are known to depress ecological health and environmental safety (Deng et 
al., 2013). Also, numerous studies have confirmed that the improper use of antibiotics 
and disinfectants would increase the risk of drug resistance of pathogenic microbes, 
threaten food safety and human health and disturb or destroy the normal bacterial 
populations in any aquaculture environment (Lalumera et al., 2004; Balcazar et al., 2006; 
Defoirdt et al., 2007) which make them unfeasible to use in BFT.  
Positive effects on water quality, health and growth of fish (and other livestock 
species), due to different additives, such as prebiotics, essential oils and organic acids, 
have been established when such additives are incorporated in the feed or in the culture 
water (Anuta et al., 2016; Azhar et al., 2016; Gracia-Valenzuela et al., 2014; Kim et al., 
2011; Adams and Boopathy, 2013; da Silva et al., 2013). However, the mode of action 
has yet to be determined for each additive to achieve higher shrimp production and 
improve water quality when added to the culture water or to the feed used in a BFT 
system. A major deterrent to using additives in the culture water is the amount required 
per unit of production. However, with the demonstration that shrimp can be cultured 
using shallow water depths of less than 30 cm, resulting in much greater production 
7 
levels of up to 25 kg/m2 per crop (Lawrence et al., 2015), the use of additives in shallow-
water culture systems may be commercially feasible. Potential changes in bacterial 
communities present in biofloc, and their effects on shrimp intestine, gills and 
hepatopancreas, have not yet been documented when different additives such as 
prebiotics, organic acids and their salts and/or essential oils are added to the BFT system. 
The usage of prebiotics, organic acids and essential oils in different animal 
industries to increase growth or enhance animal health will be described next as well as 
different future perspectives on their use to increase shrimp growth and enhance its 
health. 
I.3.1 Prebiotics 
Although the definition of prebiotics has passed through several reviews and 
modifications, it is well accepted that a genuine prebiotic needs to fulfil three criteria: (1) 
resist gastric acidity, hydrolysis by mammalian enzymes and gastrointestinal absorption, 
(2) undergo fermentation by microbiota, and (3) selectively stimulate the growth and/or 
activity of bacteria associated with health and well-being (Venema and do Carmo, 2015). 
Studies have been conducted to evaluate the efficacy of some prebiotics in shrimp 
culture, finding improvements in weight gain and feed efficiency ratio (FE) (Zhou et al., 
2007; Genc et al., 2007). Zhou et al. (2007) also observed a displacement of potentially 
pathogenic bacteria in the gastrointestinal tract by mostly Lactobacillus sp., known to be 
beneficial to the health of shrimp. Very little information has been found on the use of 
prebiotics in a BFT system for shrimp culture and how they could improve production 
parameters and water quality (Crockett and Lawrence, 2017). 
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I.3.2 Organic acids and their salts 
Organic acids and their salts are generally regarded as safe diet additives and are 
receiving increasing attention due to their strong antibacterial and prophylactic properties 
against various pathogenic bacteria. These acids also have been shown to trigger 
beneficial effects on mineral absorption, nutrient digestibility and growth performance of 
various organisms. It is believed that the primary antibacterial action of organic acids is 
by altering the cell cytoplasm pH of bacteria and those that are sensitive to such changes 
are inhibited or killed, thus reducing the numbers of harmful bacteria within the 
gastrointestinal tract of the host animal (Booth and Stratford, 2003). Some organic acids 
are known to inhibit various Vibrio strains in vitro, but are highly dependent on type and 
level (da Silva et al., 2013; Defoirdt et al., 2006; Ng and Koh, 2011) when tested in vivo 
with various aquatic species. 
Da Silva et al. (2013) concluded that the use of organic acid salts could improve 
marine shrimp nutrition and health and that propionate has the greatest potential for use 
as a diet supplement for L. vannamei. Meanwhile, Romano et al. (2015) found that an 
organic acid blend can substantially improve productivity and resistance to pathogenic 
bacteria and may be a viable alternative to the use of antibiotics in the shrimp industry. 
There was no information found in the literature on the use of organic acids in a BFT 
system for shrimp culture. 
 
I.3.3 Essential oils 
Essential oils are environmentally friendly alternatives to antibiotics for the 
control of disease vectors, bacteria and parasites. Essential oils have been used in poultry 
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and fish nutrition as feed additives to improve performance indices and feed utilization 
via activation of digestive system structure and function, enhancing absorption and 
metabolism of nutrients, altering the gut microbiota, and reducing hazardous compounds 
and free radicals from interacting with cellular compounds (Ezzat Abd El-Hack et al., 
2016). There is no information on the effect and mode of action of essential oils when 
added to feed on water quality and shrimp health and growth when cultured under biofloc 
conditions. 
Three trials were conducted to test the effect those various additives may have on 
bacterial flora which form biofloc particles (BFP) and which may be present in shrimp 
gill tissue (GT), hepatopancreas (HP) and intestinal contents (IC). 
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CHAPTER II 
EFFECT OF PREBIOTICS ADDED TO THE CULTURE WATER ON 
BACTERIAL COMPOSITION OF BIOFLOC AND PACIFIC WHITE SHRIMP 
Litopenaeus vannamai INTESTINE, GILLS AND HEPATOPANCREAS 
 
II.1 Introduction 
Antibiotics and disinfectants are additives commonly used in aquaculture to 
counter disease outbreaks; however, they are known to depress ecological health and 
environmental safety (Deng et al., 2013). Also, numerous studies have confirmed that the 
improper use of antibiotics and disinfectants would increase the risk of drug resistance of 
pathogenic microbes, threaten food safety and human health and disturb or destroy the 
normal bacterial populations in any aquaculture environment (Lalumera et al., 2004; 
Balcazar et al., 2006; Defoirdt et al., 2007) which make them unfeasible to use in Biofloc 
Technology (BFT) systems, a system in which bacterial populations control water quality 
and provide nutrients to the culture organisms. 
Prebiotics are composed of natural, fermentable oligosaccharides that are not 
digested by the host but provide a source of metabolizable energy to some genera of 
bacteria that confer beneficial properties to the host (Gibson et al., 2004). Prebiotics have 
been proposed as an alternative to the use of antibiotics and disinfectants. Although the 
definition of prebiotics has passed through several reviews and modifications, it is well 
accepted that a genuine prebiotic needs to fulfil three criteria: (1) resist gastric acidity, 
hydrolysis by mammalian enzymes and gastrointestinal absorption, (2) undergo 
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fermentation by microbiota, and (3) selectively stimulate the growth and/or activity of 
bacteria associated with health and well-being (Venema and do Carmo, 2015).  
The effect of prebiotics have been studied to a limited extent for crustacean 
aquaculture (Daniels and Hoseinifar, 2014; Merrifield and Ringø, 2014). Studies have 
been conducted to evaluate the efficacy of some prebiotics in shrimp culture, finding 
improvements in weight gain and feed efficiency ratio (FE) (Zhou et al., 2007; Genc et 
al., 2007).  
Normally, prebiotics are provided to the cultured organisms through their feed, 
however, it has been proven that shrimp consume biofloc particles as a supplemental 
source of nutrients (Ray et al., 2017). For this reason, it can be assumed that, with the 
addition of prebiotics to the culture water, the effect that prebiotics have on bacteria 
associated with biofloc particles can ultimately have an effect on the shrimp internal 
bacterial composition. However, to my knowledge, no study on the effect of prebiotics 
added to the culture water on shrimp production and microbiology has been developed on 
shrimp cultured under biofloc conditions. Therefore, the objective of this study was to 
evaluate the effect of prebiotics and non-prebiotic carbohydrates on bacteria profiles in 
biofloc particles and Pacific white shrimp, Litopenaeus vannamei, hepatopancreas, 
intestine and gills when added directly to the culture water of a biofloc-based shallow-
water research system.  
The prebiotics fructooligossacharide (FOS), galactooligosaccharide (GOS), 
mannan-oligosaccharide (MOS) and inulin (INU), as well as the non-prebiotic soluble 
carbohydrates wheat starch (WSt) and sucrose (SUC), were added to the culture water of 
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a BFT research system for the culture of L. vannamei to evaluate their effect on biofloc 
and shrimp bacterial communities, shrimp production and health and on water quality. 
 
II.2 Materials and methods 
 
II.2.1 Experimental conditions  
A 26-day trial (Trial I) was conducted in the trū® Shrimp Company experimental 
station located in Balaton, MN, USA to evaluate the effect of different prebiotics on 
shrimp production and water quality, and on bacterial composition of biofloc and shrimp 
hepatopancreas, gills and intestinal contents. Thirty-six tanks (0.457 m × 0.457 m × 0.280 
m) containing an independent heater, an automatic 48-h feeder, and two air stones were 
used in this study. Tanks were filled to 20-cm depth with artificial seawater of 28 g/L 
salinity and maintained at 30.0 ± 1.0oC. To maintain buffering capacity, sodium 
bicarbonate (NaHCO3) was added if alkalinity levels fell below 180 mg/L. Application 
levels were determined using the following formula: 
 
NaHCO3 needed per tank (g) = ((deficiency in alkalinity (mg/L) / concentration of 
HCO3 in NaHCO3 (72.646 (%); 0.72646)) × tank volume (L)) / 1,000 (mg/g) 
 
Water lost due to evaporation was replaced weekly with reverse osmosis water to 
maintain salinity at 28 ± 1 g/L. All tanks were operated as a zero-water exchange BFT 
system. During the autotrophic phase (ATr; see Chapter I, subheading I.2), autotrophic 
bacteria were promoted and maintained from the initial day until Imhoff cone readings 
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reached 3 mL/L.  Only during the autotrophic phase, a nitrifying bacteria inoculum 
(Turbo Start 900, FritzZyme, Mezquite, TX, USA) was added to the culture water 
according to manufacturer recommendations, and shrimp were given feed pellets and 
fines formulated to contain 35% crude protein (CP) (as-fed basis) at a mean of 3.33 g/day 
per tank and 0.037 g/L, respectively. Heterotrophic phase (see Chapter I, subheading I.2) 
was promoted when Imhoff cone readings reached 3 mL/L. Only during heterotrophic 
phase, total ammonia nitrogen (TAN; NH3/NH4
+), nitrite (NO2
-) and nitrate (NO3
-) levels 
were maintained at <3, <5 and <100 mg/L, respectively, by feeding a 23% crude protein 
feed and by adding the prebiotics fructooligosaccharide (FOS), galactooligosaccharide 
(GOS), inulin (INU) and mannan-oligosaccharide (MOS) and the non-prebiotic soluble 
carbohydrates wheat starch (WSt) and sucrose (SUC) into the culture water of each tank 
according to its treatment assignment. The prebiotics and non-prebiotics soluble 
carbohydrates were added to each tank on feeding days, at a rate of 3% of the feed weight 
provided. 
 
II.2.2 Shrimp 
 Post-larvae weighing 0.003 g arrived at experimental station from a commercial 
hatchery (Shrimp Improvement Systems, SIS, Inc., Islamorada, Florida, USA) and were 
acclimated in a nursery tank filled with artificial seawater of 28.0 ± 0.5 g/L salinity, at 
29.0 ± 1.0oC. Shrimp in the nursery tank were fed daily with a commercial feed (Ziegler 
Bros., Inc., Gardners, PA, USA) until reaching a mean individual weight of 6 g. Shrimp 
with no visual signs of disease or stress were collected from the nursery tank and 
individually weighed. Shrimp weighing 6.0 ± 0.5 g were stocked into each tank at a 
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density of 15 shrimp/tank. Only group weight was recorded and mean individual weight 
was calculated as well as initial biomass based on water volume of the experimental tanks 
(g/m3) (Table II.1). Mortality counts and weights were recorded and replaced with the 
same size shrimp only during a 3-day acclimation period. When the trial started, a small 
net was used to carefully check for mortalities and leftover feed without disturbing the 
living organisms. Mortalities were recorded and discarded.   
 
Table II.1. Initial shrimp group weight, biomass and 
individual shrimp weight for Trial I.1 
Treatment2 
Group 
weight  
(g) 
Biomass 
(g/m3) 
 Individual 
mean weight 
(g) 
FOS 89.6 2,144.5 6.0 
GOS 90.3 2,159.9 6.0 
INU 89.9 2,150.9 6.0 
MOS 91.1 2,180.2 6.1 
WSt 89.2 2,133.3 5.9 
SUC 91.3 2,184.5 6.1 
    
PSE3 0.41 9.81 0.03 
1 Values are expressed as means per treatment. 
2 FOS = fructooligosaccharide; GOS = galactooligosaccharide; 
INU = inulin; MOS = mannan-oligosaccharide; WSt = wheat 
starch; SUC = sucrose. 
3 PSE = pooled standard error of treatment means (n = 6). 
 
II.2.3 Feed and feeding management 
Shrimp in Trial I were fed the same reference diet (Table II.2). Two diets were 
prepared 8 days before shrimp were stocked in the experimental tanks. Each diet was 
formulated to contain different protein concentrations. To prepare the diets, all dry 
ingredients were weighed and mixed in an industrial mixer for 15 min until a completely 
homogenized mixture was achieved. Next, the dry mixture was blended with sodium 
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hexametaphosphate and alginate (Table II.2) previously mixed with 150 mL of deionized 
water per kg of dry feed using a hand mixer (Sunbeam Products Inc., Milford, MA) until 
an appropriate mash consistency was obtained for extrusion. Fish and soybean oil were 
also added during this step. Extrusion was made using a meat chopper attachment (Model 
A-800, Hobart Corporation, Troy, OH, USA) fitted with a 3-mm die. Moist feed strands 
were dried on wire racks in a forced air oven at 35oC to a moisture content of 8-10%. 
After a 24-h drying period, feed was milled and sifted into the appropriate size for shrimp 
consumption, bagged, and stored at 4oC until used to feed the shrimp or for proximate 
analysis composition according to the AOAC (1990) procedures for dry matter, lipid, and 
ash contents and according to the Dumas method (AOAC, 2005) for crude protein 
composition. Proximate composition analyses of feed samples were performed in 
duplicate. 
Formulation as well as ash, protein and lipid composition of each diet can be 
found in Table II.2. Fines were obtained by grinding the higher protein content diet and 
sieving to obtain particles between 0.595-0.420 mm. During the autotrophic phase (day 
0-4), the higher protein content diet was used to feed shrimp and fines were added 
directly into the culture water. Feed and fines were calculated and actual amounts 
supplied can be found in Table II.3. The lower protein content diet was used during the 
heterotrophic phase (day 5 until termination) in order to increase the carbon:nitrogen 
(C:N) ratio and to promote the dominance of heterotrophic bacteria (Table II.3). Feed 
efficiency (FE) was adjusted based on biofloc concentration in the tanks, as can be noted 
in Table II.3, because, as demonstrated, shrimp can supplement their nutritional 
requirements with biofloc particles (Ray et al., 2017). The analyzed composition of the 
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diets fed to shrimp during Trial I were slightly higher than the target protein content 
(Table II.2) possibly due to some fiber that escaped while mixing. 
Based on previous experience, it was expected that, for this size, shrimp were 
going to grow linearly. A feed curve based on number of shrimp, expected shrimp daily 
growth and FE was used to determine the expected feed regimen offered to each tank 
(Expected feed regimen = (Shrimp count × Expected weight increase (g)) × FE) (Table 
II.3). Each 48-h feeder was loaded every other day based on the expected feed regimen of 
2 days with adjustments based on leftover feed, water quality and mortalities.  
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Table II.2. Formulation (%) of the two diets used for 
Trial I with determined ash, protein and lipid 
proximate composition (g/kg). 
Protein content 
Ingredient (%) 35% 23% 
Squid muscle meala 30.00 21.70 
Wheat starchb 28.75 41.75 
Fish mealc 8.00 8.00 
Soy protein isolatedd 5.70 0.00 
Dicalcium phosphateb 4.20 4.60 
Lecithin, dry, 95%c 4.00 4.00 
Diatomaceous earthe 3.80 3.70 
Cellulosef 3.20 3.20 
Calcium carbonatef 2.50 2.20 
Alginate (Manucol DM)g 2.00 2.00 
Potassium chloridef 1.90 2.00 
Magnesium oxideh 1.60 1.60 
Sodium hexametaphosphatef 1.00 1.00 
Sodium chloridef 0.70 0.90 
Menhaden fish oilc 0.60 1.10 
Soybean oili 0.60 0.70 
Vit/Min premixk 1.25 1.25 
Cholesterola 0.20 0.20 
DL-Methionine
j 0.00 0.10 
Proximate composition (g/kg, dry weight) 
Crude Protein 385.5 271.6 
Crude Lipids 82.5 81.6 
Ash 131.4 189.5 
a Zeigler Bros., Inc. Gardners, PA, USA. 
b MP Biomedicals Santa Ana, CA, USA. 
c ADM Co. Chicago, IL, USA. 
d Solae LLC, St. Louis, MO, USA. 
e Absorbent Products LTD. 
f Fisher Scientific. 
g FMC BioPolymer. 
h Prince Agri Products. 
i Consumer's Supply. 
j Evonik Degussa Corporation. 
k Composition given in Appendix. 
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Table II.3. Expected feed curve based on shrimp count, expected weight increase and 
feed efficiency with actual fines and feed provided for Trial I. 
Day 
Shrimp 
count 
Expected 
weight 
(g) 
Expected 
weight 
increase 
(g) 
FE 
Expected 
feed 
regimen 
(g) 
35% 
CP 
fines 
(g) 
Feed 
protein 
% 
Actual 
feed 
provided 
(g) 
ACN 15 6.00 - 1.30 2.925 - 35 5.850 
ACN 15 6.15 0.15 1.30 2.925 - - - 
ACN 15 6.30 0.15 1.20 2.700 - 35 5.400 
0 15 6.45 0.15 1.20 2.700 3.0 - - 
1 15 6.60 0.15 1.00 2.250 3.0 35 5.175 
2 15 6.75 0.15 1.10 2.925 3.0 - - 
3 15 6.90 0.15 1.10 2.925 3.0 35 5.625 
4 15 7.05 0.15 1.10 2.700 3.0 - - 
5 15 7.20 0.15 1.10 2.700 - 23 5.175 
6 15 7.35 0.15 1.10 2.475 - - - 
7 15 7.50 0.15 1.10 2.475 - 23 4.725 
8 15 7.65 0.15 1.00 2.250 - - - 
9 15 7.80 0.15 1.00 2.250 - 23 4.500 
10 15 7.95 0.15 1.00 2.250 - - - 
11 15 8.10 0.15 0.90 2.025 - 23 4.050 
12 15 8.25 0.15 0.90 2.025 - - - 
13 15 8.40 0.15 0.90 2.025 - 23 4.050 
14 15 8.55 0.15 0.90 2.025 - - - 
15 15 8.70 0.15 0.90 2.025 - 23 3.825 
16 15 8.85 0.15 0.80 1.800 - - - 
17 15 9.00 0.15 0.80 1.800 - 23 3.600 
18 15 9.15 0.15 0.80 1.800 - - - 
19 15 9.30 0.15 0.80 1.800 - 23 3.600 
20 15 9.45 0.15 0.80 1.800 - - - 
21 15 9.60 0.15 0.80 1.800 - 23 3.600 
22 15 9.75 0.15 0.80 1.800 - - - 
23 15 9.90 0.15 0.80 1.800 - 23 3.600 
24 15 10.05 0.15 0.80 1.800 - - - 
25 15 10.20 0.15 0.80 1.800 - 23 1.800 
26 15 10.35 0.15 0.80 0.000 - - TMN 
ACN = acclimation period; FE = feed efficiency; TMN = termination. 
Expected feed regimen = (shrimp count × expected weight increase) × FE. 
Feed provided = actual feed loaded on 48-h feeders with the amount calculated for 2 days 
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II.2.4 Experimental treatments 
Non-prebiotic carbohydrates (wheat starch [WSt; MP Biomedicals Santa Ana, 
CA, USA], and sucrose [SUC; table sugar; Nash Finch Company, Minneapolis, MN, 
USA]) were used in this study as controls to evaluate the effect of soluble prebiotics. 
Prebiotics used in this study were short-chain fructooligosaccharide (sc-FOS [FOS in this 
manuscript]; Ingredion Incorporated, Indianapolis, IN, USA), galactooligosaccharide 
(GOS; Ingredion Incorporated, Indianapolis, IN, USA), mannan-oligosaccharide (Bio-
MOS [MOS in this manuscript]; Alltech, Nicolasville, KY, USA) and inulin (INU; JeTsu 
Technology Limited, London, UK). Each treatment was randomly assigned to six 
replicate tanks for a total of 36 tanks in Trial I. Only during the heterotrophic phase, each 
additive was mixed every other day directly into the culture water of each experimental 
tank according to its treatment assignment to increase the C:N ratio and to promote 
heterotrophic bacteria dominance. The amount of carbohydrate added was based on feed 
rate (carbohydrate added (g) = feed provided (g) × 0.03). A carbohydrate addition of 3% 
of the feed provided was found to be enough to increase C:N to promote heterotrophic 
dominance and control water quality. 
 
II.2.5 Data acquisition and analyses 
  
II.2.5.1 Water quality 
Dissolved oxygen (DO), temperature and salinity of the culture water were 
measured daily using a YSI 85 oxygen/conductivity instrument (YSI, Yellow Springs, 
Ohio, USA). pH was monitored daily using a YSI pH 100 (YSI). Total ammonia-
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nitrogen, nitrites, nitrates and alkalinity were recorded weekly from each tank using a 
Hach DR6000 spectrophotometer (Hach, Loveland, Colorado, USA) according to 
manufacturer instructions.  
 
II.2.5.2 Biofloc volume and proximate composition 
To measure biofloc level in the water, water samples were collected from each 
tank weekly using a glass beaker and poured into Imhoff cones. After 30 min, water in 
the Imhoff cones was gently stirred using a glass stirring rod. Fifteen minutes later, the 
settled biofloc volume was recorded from the bottom of the cone in mL/L. All tools used 
were thoroughly disinfected with Virkon Aquatic (Syndel USA, Ferndale, WA, USA) 
before they were in contact with the culture water to avoid cross-contamination.  
Proximate composition analyses was performed in samples collected immediately 
before switching to heterotrophic phase (during autotrophic phase; ATr) and on 
termination day from each experimental treatment. One liter of culture water was 
collected from each tank and poured into Imhoff cones for 30 min that allowed biofloc to 
completely settle to the bottom. Carefully, biofloc samples were collected from the 
bottom of the Imhoff cones by siphoning the upper phase of the water and removing the 
bottom cap of to imhoff cone to collect the biofloc into 5 mL tubes. Biofloc was then 
analyzed for proximate composition according to the AOAC (1990) procedures for dry 
matter, lipid, and ash contents and according to the Dumas method (AOAC, 2005) for 
crude protein composition. Proximate composition of biofloc was performed in duplicate 
per sample unless specified otherwise. 
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II.2.5.3 Hemolymph 
On the morning of day 26, 24-hr after loading feeders and 1-hr before 
termination, hemolymph was withdraw from the ventral sinus of one shrimp per tank of 
three randomly chosen tanks per treatment using tuberculin syringes (1 mL 22G x 32 
mm) to determine total hemocyte counts. Before hemolymph was withdrawn, syringes 
were loaded with 300 uL of anticoagulant 1 (Table II.4). Next, the needle was carefully 
inserted into the ventral sinus to reach the hematopoietic tissue without breaking the 
ventral nerve. Slowly, a 50-100 uL of hemolymph were extracted. The needle was 
removed and the exact amount collected was recorded. The sample was carefully poured 
in a 5-mL microcentrifuge tube. Microcentrifuge tubes contents were gently 
homogenized using a vortex until hemolymph and anticoagulant 1 were completely 
mixed. Ten microliters of the mixture were mixed with 90 uL of anticoagulant 2. Samples 
were gently homogenized with a vortex and total hemocyte counts per milliliter were 
determined using a Neubauer hemocytometer.  
 
Table II.4. Anticoagulant formula. 
Anticoagulant 1 
Reagent For 1 L: 
Trisodium citrate (294.1 g/mol) 7.94 g 
NaCl (54.88 g/mol) 22.49 g 
Glucose (Anyhdrose dextrose) (180 g/mol) 20.71 g 
Distilled water 1 L 
Anticoagulant 2 
Reagent For 500 mL: 
Anticoagulant 1 400 mL 
Formaldehyde 100 mL 
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II.2.5.4 Sample collection for denaturing gradient gel electrophoresis
PCR-Denaturing gradient gel electrophoresis (DGGE), a genetic fingerprinting 
technique that examines bacterial diversity based upon electrophoresis of PCR-amplified 
16S rDNA fragments using polyacrylamide gels (Muyzer et al., 1993), was selected to 
compare bacterial communities among treatments. 
For DGGE, biofloc was collected right before switching to the lower protein 
content diet (during the autotrophic phase) and during termination from each treatment. 
Approximately, 50-mL of water from three randomly chosen tanks per treatment were 
poured into sterile Stericup® vacuum filtration systems (Millipore Corporation, Billerica, 
MA, USA). Biofloc that remained on the membrane was collected, using a sterile 
dissecting spatula, into sterilized 1.5-mL microcentrifuge tubes. Samples were stored at -
80oC until analyzed. 
Shrimp intestines, hepatopancreas and gills from each treatment were aseptically 
collected for DGGE analysis on stocking day (initial sample; INL), immediately before 
switching to the lower protein content diet (autotrophic phase; ATr) and during 
termination from each treatment. The weights of the shrimp collected for DGGE were 
recorded for final production data. 
II.2.5.5 Termination and harvest
Shrimp weight, length and hepatopancreas weight of one shrimp per tank from 
three randomly chosen tanks per treatment were recorded to calculate a condition factor 
(K; according to Chow and Sandifer, 1991) and the hepatosomatic index. 
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During termination, water levels in all tanks were reduced and all shrimp were 
harvested one tank at a time. The final number of shrimp and shrimp group weight were 
recorded per tank to calculate mean final individual weight, weight gain and survival. 
Also, on termination day one shrimp per tank from three randomly chosen tanks per 
treatment was stored for proximate composition according to the AOAC (1990) 
procedures for dry matter, lipid, and ash contents and to the Dumas method (AOAC, 
2005) for crude protein composition. Proximate composition of shrimp muscle was 
performed in duplicate samples unless specified otherwise. 
 
II.2.6 DNA isolation and PCR 
Triplicate samples of biofloc particles (BFP), intestinal contents (IC), 
hepatopancreas (HP) and gills tissue (GT) from each treatment were thawed and pelleted 
by centrifugation at 5,000 × g for 5 min. Approximately 0.5 g of pelleted samples in each 
replicate was placed in a sterile microcentrifuge tube for genomic DNA isolation. The 
pellet was suspended in 180 µL of lysis buffer (20 mM Tris-HCl, pH 8.0, 2 mM EDTA, 
1.2% Triton-100, 20 mg lysozyme mL-1 (Sigma Chemical Company, Sant Louis, MO, 
USA)) and incubated for 30 min at 37°C. Genomic DNA isolation was conducted using a 
QIAamp® DNA Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s 
instructions. Once isolated, DNA was amplified through PCR as described by Hume et al. 
(2003), using bacteria-specific PCR primers to conserved regions of the variable V3 
region of 16S rDNA. 
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II.2.7 Denaturing gradient gel electrophoresis 
Denaturing gradient gel electrophoresis was performed as described by Hume et 
al. (2003) using polyacrylamide gels (8% v/v, acrylamide-bisacrylamide (BioRad 
Laboratories, Richmond, CA) ratio 37.5:1). Electrophoresis was performed for 17 h at 60 
V using a DCode Universal Mutation Detection System (BioRad). Subsequently, gels 
were stained with SYBR Green I (1:10,000 dilution; Sigma) and digitalized for analysis.  
The analysis of DGGE band pattern relatedness was determined using 
GelCompare II, v6.6 11 (Applied Maths, Austin, TX) based on the Dice similarity 
coefficient (SC) and the unweighted pair group method using arithmetic averages for 
clustering. Comparisons between sample band patterns are expressed as a similarity 
coefficient (SC) and results were translated as ≥95 = likely the same or identical, 90-94 = 
very similar, 85-89 = similar, 80-84 = somewhat similar, and ≤79 = not similar. 
 
II.2.8 Calculations and statistical analyses 
The responses utilized to compare production parameters among treatments in this 
study were calculated as follow: 
 Percent weight gain, % = [(final weight (g) – initial weight (g) ) / (initial weight 
(g))] × 100 
 Feed efficiency ratio (FE) = [weight gain (g) / dry feed offered (g)] 
 Percent survival, % = [(final shrimp number – initial shrimp number) / (initial 
shrimp number)] × 100 
 Condition factor (K) = [body weight (g) / (body length (mm))3)] × 105 
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 Hepatosomatic index (HSI) = [hepatopancreas weight (g) / body weight (g)] × 
100 
 Total hemocyte count (THC) = (cells counted × dilution factor × 1000) / volume 
of grid (0.1 mm3) 
 
Data were analyzed for normality and homogeneity of variances assumptions 
(Shapiro-Wilk test and Levene’s test, respectively). Data were then subjected to one-way 
analysis of variance (ANOVA) to detect significant differences among treatments (p ≤ 
0.05). Significant one-way ANOVA was followed by a post hoc multiple comparison test 
(Student’s LSD). The analysis was conducted using the SAS 9.2 statistical package (SAS 
Institute Inc., Cary, NC, USA). 
 
II.3 Results 
Mean dissolved oxygen, water temperature, salinity and pH are shown by 
treatment in Table II.5. Final weight, weight gain, FE, survival, HSI and THC or 
condition factor score showed no significant differences among treatments (Table II.6). 
Mean biofloc concentration of the WSt treatment was lower (p ≤ 0.05) than the rest of the 
treatments (Figure II.1). Significant differences in water quality were only observed in 
day 23 when water of tanks to which INU was added had a higher nitrate concentration 
than the water of tanks containing WSt (Tables II.7 and II.8). 
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Table II.5. Dissolved oxygen (mg/L), salinity (g/L), 
temperature (oC) and pH mean results from daily 
observations during Trial I.1 
Treatment2 
Dissolved 
Oxygen 
(mg/L) 
Salinity 
(g/L) 
Temperature 
(oC) pH 
FOS 5.61 28.49 30.03 7.95 
GOS 5.58 28.52 30.13 7.96 
INU 5.59 28.50 30.13 8.02 
MOS 5.60 28.51 29.95 7.98 
WSt 5.66 28.63 30.03 8.02 
SUC 5.63 28.54 30.18 8.02 
     
PSE3 0.02 0.03 0.08 0.01 
1 Values represent mean per treatment.  
2 FOS = fructooligosaccharide; GOS = galactooligosaccharide; INU = 
inulin; MOS = mannan-oligosaccharide; WSt = wheat starch; SUC = 
sucrose. 
2 PSE = pooled standard error of treatment means (n = 6; mean value of 
six tanks per treatment). 
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Table II.6. Final weight, weight gain, feed efficiency and survival as well as K, 
HSI and THC of shrimp cultured with prebiotics fructooligosaccharide, 
galactooligosaccharide, inulin and mannan-oligosacchaide and non-prebiotics 
wheat starch and sucrose added into the culture water for Trial I.1
Treatment2 
Final 
weight 
(g) 
Weight 
gain 
(%) FE 
Survival 
(%) K HSI THC 
FOS 9.7 163 1.3 96.7 0.85 0.04 1.78 
GOS 9.7 161 1.3 96.7 1.10 0.04 1.49 
INU 9.5 158 1.3 97.8 0.90 0.04 1.19 
MOS 9.6 158 1.3 98.9 0.92 0.04 1.36 
WSt 9.7 162 1.2 97.8 0.91 0.03 1.70 
SUC 9.6 157 1.4 97.8 0.90 0.04 1.43 
PSE3 0.09 1.47 0.03 0.60 0.03 0.00 0.17 
Anova 
(Pr > F) 
0.972 0.813 0.847 0.916 0.082 0.428 0.945 
1 Values represent mean per treatment.
2 FOS = Fructooligosaccharide; GOS = Galactooligosaccharide; INU = inulin; MOS = mannan-
oligosaccharide; WSt = wheat starch; SUC = sucrose. FE = feed efficiency; K = condition factor; 
HSI = hepatosomatic index; THC = total hemocyte count (107 cells/mL). 
3 PSE = pooled standard error of treatment means (final weight, weight gain, FE and survival: n=6; 
K, HSI and THC: n = 3). 
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Figure II.1. Mean biofloc levels (mL/L) of tanks subjected to prebiotics 
fructooligosaccharide, galactooligosaccharide, inulin or mannan-oligosaccharide 
or non-prebiotic carbohydrates wheat starch or sucrose added directly to the water 
during Trial I.1,2  
1 Values are expressed as means ±   PSE (n = 6) of the weekly biofloc readings obtained from 
Imhoff cones. Different superscript letter means significantly different (p ≤ 0.05). 
2 FOS = fructooligosaccharide; GOS = galactooligosaccharide; INU = inulin; MOS = mannan- 
oligosaccharide; WSt = wheat starch; SUC = sucrose. 
Table II.7. Mean values over time for total-ammonia nitrogen (TAN) and nitrites of 
tanks with prebiotics fructooligosaccharide, galactooligosaccharide, inulin or 
mannan-oligosaccharide or non-prebiotic carbohydrates wheat starch or sucrose 
added into the culture water for Trial I.1 
Total Ammonia-Nitrogen Nitrites 
Treatment2 
Day 
2 
Day 
9 
Day 
16 
Day 
23 
Day 
2 
Day 
9 
Day 
16 
Day 
23 
FOS 1.34 0.07 0.07 0.05 0.70 0.13 0.12 0.08 
GOS 1.75 0.06 0.06 0.06 0.80 0.15 0.17 0.07 
INU 1.61 0.07 0.05 0.06 1.01 0.10 0.10 0.10 
MOS 1.51 0.09 0.06 0.05 0.72 0.18 0.09 0.10 
WSt 1.84 0.07 0.06 0.05 0.80 0.10 0.12 0.14 
SUC 1.68 0.06 0.06 0.05 0.88 0.13 0.12 0.07 
PSE3 0.22 0.00 0.00 0.00 0.05 0.02 0.01 0.01 
Anova 
(Pr>F) 
0.991 0.703 0.554 0.580 0.563 0.712 0.121 0.144 
1 Values represent treatment means of the weekly observations from six replicate tanks per treatment.
2 FOS = fructooligosaccharide; GOS = galactooligosaccharide; INU = inulin; MOS = mannan- 
oligosaccharide; WSt = wheat starch; SUC = sucrose. 
3 PSE = pooled standard error of treatment means (n = 6). 
a
a
a
a
b
a
3.5
4
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5
5.5
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6.5
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Average biofloc levels ml/L
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Table II.8. Mean values over time for nitrates and alkalinity of tanks with prebiotics 
fructooligosaccharide, galactooligosaccharide, inulin or mannan-oligosaccharide or 
non-prebiotic carbohydrates wheat starch or sucrose added into the culture water for 
Trial I.1 
Nitrates Alkalinity 
Treatment2 
Day 
2 
Day 
9 
Day 
16 
Day 
23 
Day 
2 
Day 
9 
Day 
16 
Day 
23 
FOS 5.4 18.2 28.8 41.1ab 185.3 163.2 176.2 165.5 
GOS 4.9 16.8 25.9 36.8ab 194.0 164.3 175.5 165.5 
INU 5.1 18.2 26.9 43.4a 182.0 184.2 174.5 166.2 
MOS 4.4 14.5 27.3 35.2ab 199.5 177.2 176.5 164.2 
WSt 5.5 17.9 26.8 33.4b 185.7 209.2 192.8 165.8 
SUC 5.4 16.7 28.8 41.5ab 180.7 161.3 174.2 161.7 
PSE3 0.22 0.71 1.44 1.24 4.20 5.56 3.98 2.29 
Anova 
(Pr>F) 
0.700 0.669 0.993 0.016 0.703 0.094 0.771 0.995 
1 Values represent treatment means of the weekly observations from six replicate tanks per treatment.
2 FOS = fructooligosaccharide; GOS = galactooligosaccharide; INU = inulin; MOS = mannan- 
oligosaccharide; WSt = wheat starch; SUC = sucrose. 
3 PSE = pooled standard error of treatment means (n = 6). Means in columns with different superscript 
are significantly different (p ≤ 0.05). 
Proximate analyses of biofloc samples showed that, during the autotrophic phase 
(ATr), a higher (p ≤ 0.05) protein content was found in biofloc than the rest of the 
treatments (Table II.9). No significant differences were found in any of the treatments for 
lipids or ash composition. Proximate composition showed that muscle of shrimp given 
MOS had a higher (p ≤ 0.05) lipid content than shrimp muscle of the GOS, INU and WSt 
treatments. Also, shrimp muscle of the WSt treatment had higher (p ≤ 0.05) lipid 
concentration than the GOS and INU treatment. No significant differences were observed 
for ash or protein contents of shrimp muscle (Table II.9). 
In terms of bacterial community present in the biofloc particles (Figure II.2), 
although there was little similarity at 61.5%SC between bacterial communities from ATr 
and WSt, these two communities were more similar to each other than to bacterial 
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communities from the other treatments. There was some similarity between bacterial 
communities from the GOS and MOS treatments, while bacterial communities of the 
FOS, INU and SUC treatments were very similar. However, these two groups shared only 
a 71%SC. 
Table II.9. Ash, protein and lipid contents of biofloc and muscle 
of shrimp subjected to prebiotics fructooligosaccharide, 
galactooligosaccharide, inulin and mannan-oligosaccharide and 
non-prebiotic carbohydrates wheat starch and sucrose added into 
the culture water for Trial I.1
Biofloc Muscle 
Treatment2 Ash Protein Lipids Ash Protein Lipids 
ATr 72.9 13.6a 7.7 
FOS 72.3 11.2b 6.4 6.3 85.1 6.0ab 
GOS 72.3 10.2b 5.6 6.5 84.9 5.4b 
INU 73.7 10.3b 6.1 6.4 87.9 5.5ab 
MOS 73.2 10.4b 6.0 6.3 84.4 6.7a 
WSt 71.1 10.7b 6.8 5.7 86.0 6.4ab 
SUC 73.6 10.7b 5.9 6.5 83.8 6.0ab 
PSE3 0.30 0.25 0.34 0.21 0.35 0.03 
Anova 
(Pr>F) 
0.218 0.0001 0.829 0.916 0.155 0.027 
1 Values represent means of three replicate tanks.
2 ATr = Autotrophic phase; FOS = Fructooligosaccharide; GOS = 
Galactooligosaccharide; INU = inulin; MOS = mannan-oligosaccharide; WSt 
= wheat starch; SUC = sucrose. 
3 PSE = pooled standard error of treatment means (n = 3). 
Bacterial community profiles of bacteria present in gill tissue are shown in Figure 
II.3. Profiles from gills with FOS and INU addition were very similar to each other and 
these were similar to the bacterial community of the GOS treatment. Bacterial 
communities of the FOS, INU and GOS treatments were somewhat similar to the 
bacterial community of the MOS treatment. Communities of the FOS, INU, GOS and 
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MOS treatments were not similar to the bacterial communities collected during the ATr 
phase and from the INL sample as well as the bacterial communities of the SUC and WSt 
treatments. Bacterial communities collected during the ATr phase and from the INL 
sample were somewhat similar to the bacterial communities of the SUC and WSt 
treatments. Communities collected during the ATr phase and from the INL sample were 
very similar to each other, while communities of the SUC and WSt were very similar to 
each other. 
In terms of bacterial community present in the hepatopancreas (Figure II.4), 
bacterial communities collected during the ATr phase and from the INL samples were not 
similar to each other and each of them was also not similar to the bacterial communities 
of the rest of the treatments collected on termination. Communities of the MOS and WSt 
treatments were somewhat similar to each other but they were not similar to the bacterial 
communities of the FOS, GOS and SUC treatments. Bacterial communities of the FOS 
and GOS treatments were similar to each other but they were only somewhat similar to 
the bacterial community of the SUC treatment. The bacterial community of the INU 
treatment was not similar to any other bacterial community. 
Bacterial communities present in the intestinal contents (Figure II.5) in the FOS, 
GOS and INU treatments were very similar to each other and they were similar to the 
bacterial communities of the MOS, SUC and WSt treatments. Bacterial communities 
collected during the ATr phase and from the INL sample were similar to each other but 
they were somewhat similar to the rest of the bacterial communities collected during 
termination.
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Figure II.2. Dendrogram of the biofloc particles (BFP) bacterial communities of tanks during the autotrophic phase (ATr) or 
during termination on tanks in which fructooligosaccharide (FOS), galactooligosaccharide (GOS), inulin (INU), mannan-
oligosaccharide (MOS), wheat starch (WSt) or sucrose (SUC) was added into the culture water of Trial I. 
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Figure II.3. Dendrogram of the gills tissue (GT) bacterial communities of shrimp collected during stocking day (initial sample; 
INL) or shrimp collected during the autotrophic phase (ATr) or during termination of tanks in which fructooligosaccharide 
(FOS), galactooligosaccharide (GOS), inulin (INU),mannan-oligosaccharide (MOS), wheat starch (WSt) or sucrose (SUC) was 
added to the culture water of Trial I. 
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Figure II.4. Dendrogram of the hepatopancreas (HP) bacterial communities of shrimp collected during stocking day (initial 
sample; INL) or shrimp collected during the autotrophic phase (ATr) or during termination of tanks in which 
fructooligosaccharide (FOS), galactooligosaccharide (GOS), INU (inulin), mannan-oligosaccharide (MOS), wheat starch 
(WSt) or sucrose (SUC) was added to the culture water of Trial I. 
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Figure II.5. Dendrogram of the intestinal contents (IC) bacterial communities of shrimp collected during stocking day (initial 
sample; INL) or shrimp collected during the autotrophic phase (ATr) or during termination of tanks in which 
fructooligosaccharide (FOS), galactooligosaccharide (GOS), inulin (INU), mannan-oligosaccharide (MOS), wheat starch 
(WSt) or sucrose (SUC) was added into the culture water of  Trial I. 
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II.4 Discussion
Normally, prebiotics are provided to cultured organisms through their feed, 
however, it has been proven that shrimp consume biofloc particles as a supplemental 
source of nutrients (Ray et al., 2017). For this reason, it can be assumed that, with the 
addition of prebiotics to the culture water, the effect of prebiotics on bacteria associated 
with biofloc particles can also have an effect on the shrimp internal bacterial 
composition. 
All water quality parameters associated with all treatments in the current feeding 
trial were within safe limits for shrimp culture, including alkalinity which was lower than 
targeted (Ebeling et al. 2006; Wasielesky et al., 2006). During nitrification, 
chemoautotrophs consume carbon (CO2 or HCO3) for energy and produce hydrogen ions 
(H+) which reduces the alkalinity in the water (Ebeling et al., 2006). The reduction in 
alkalinity is an indicator of the nitrification process that continuously occurred in all 
tanks due to the bacteria nitrogen assimilation. 
Final weight, weight gain, FE, survival, HIS, THC or K showed no significant 
differences among treatments. Condition factor (K) is often used to quantify an animal’s 
physical wellbeing, and is considered to be an important parameter for the management 
of aquaculture systems as it is a useful complement to estimate the growth of crustaceans 
(Rochet 2000; Araneda et al. 2008). The lack of an effect due to prebiotic addition on any 
of the production parameters evaluated in the present study is in agreement with results 
from prebiotic studies on western king prawn Penaeus latisulcatus juveniles (Van Hai et 
al., 2009), Pacific white shrimp L. vannamei (Li et al. 2007) and Indian white shrimp 
Fenneropenaeus indicus larvae and postlarvae (Hoseinifar et al., 2010). However, other 
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studies have shown production enhancement due to the use of prebiotics on P. 
semisulcatus (Genc et al., 2007) and L. vannamei (Zhou et al., 2007). For the conditions 
in which this study was conducted, the lack of effect of the prebiotics on production data 
could be possibly related to the lack of a source of stress or a pathogen during the 
experiment. Also, it has to be noted that shrimp in the studies where prebiotics had a 
positive effect on production performance were stocked at a much smaller size, had a 
much higher growth rate and stayed under experimental conditions for a longer period of 
time. Thus, the effects of prebiotics on production performance could possibly be easier 
to detect in shrimp with higher growth rate, subjected to stressful conditions or exposed 
to prebiotics for a longer period of time. 
During the experiment, no leftover feed was found during the routine checks so 
the low growth rate could be related to underfeeding. The amount of feed supplied to the 
organisms was not evaluated in this experiment as all shrimp were fed the same amount 
of feed regardless their experimental treatment. 
The mean biofloc concentration of the WSt treatment was significantly lower than 
the rest of the treatments. It is possible that, because wheat starch is a polysaccharide 
with a complex structure, it is more difficult to assimilate by microorganisms, leading to 
a lower bacterial replication rate and bacterial load in the system. In fact, bacterial 
community on biofloc of the WSt treatment was significantly different to all other 
treatments.  In contrast, all prebiotics evaluated in Trial I were oligosaccharides, and 
sucrose a disaccharide, that can be easily digested by microorganisms, so this could lead 
to a higher replication rate of microorganisms which leads to a higher microorganism 
biomass and biofloc concentration 
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Due to the addition of carbohydrate sources, heterotrophic bacteria had a substrate 
for obtaining carbon and subsequently metabolizing ammonia (Avnimelech 1999; 
Samocha et al. 2007). For this reason, total ammonia-nitrogen concentrations were 
reduced to levels tolerable to L. vannamei (Lin and Chen 2001) throughout the trial. 
During weeks 1-3 no significant differences were observed in any water quality 
parameter measured. However, on week 4, water of tanks in which INU was added had a 
higher nitrate concentration than the water of tanks were WSt was added. According to 
Silva et al. (2013), the route of nitrification occurs with successive conversions of 
ammonia to nitrite and nitrate prevalence at the end of the crop cycle. The lower nitrate 
concentration in the WSt treatment is an indicator of a lower nitrification process which 
could be explained by the lower biofloc level and the different bacterial community 
encountered in this treatment. 
A biofloc sample was collected during the autotrophic phase for proximate 
composition analysis and this turned out to have a significantly higher protein content 
than the rest of the treatments which can be explained by a higher protein content diet and 
fines supplied during the first days of the culture as biofloc particles are formed in part on 
leftover feed (Avnimelech, 2012). No significant differences were found in any of the 
prebiotic or WSt or SUC treatments collected at the end of the trial for ash, protein or 
lipids composition of biofloc. 
No information in the literature was found for nutritional composition of shrimp 
muscle when prebiotics were added to the culture water of a BFT system. However, 
studies have shown that prebiotics are involved in digestion, absorption and metabolism 
of various nutrients in terrestrial organisms (Swanson et al., 2002a; Swanson et al., 
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2002b; Steer et al., 2003). In fact, some prebiotics have been shown to influence protein 
digestion and intestinal morphology (Teitelbaum and Walker, 2002; Swanson et al., 
2002). Also, a key mechanism for which prebiotics confer health to the host is the 
production of short-chain fatty acids, which have antibacterial activity because of a 
reduction in the intestinal pH (Gibson and Roberfroid, 1995; Bindels et al., 2013). These 
studies could lead to an assumption of a possible effect of prebiotics on nutrient retention 
by the organism. Proximate composition of muscle showed that muscle of shrimp 
subjected to the MOS treatment had a higher lipid content than shrimp muscle of the 
GOS, INU and WSt treatments. Also, shrimp muscle of the WSt treatment had higher 
lipid concentration than the GOS and INU treatment. However, no significant differences 
were observed for ash or protein contents of shrimp muscle, which could be related to the 
low growth rate resulting from this experiment. 
For this study, heterotrophic bacteria dominance was promoted by providing a 
lower protein feed content and by the addition of prebiotics or other carbon sources. The 
fact that the bacterial community of biofloc particles collected during the ATr phase was 
not similar to the bacterial community of any of the biofloc particles collected during 
termination is a good indicator that the dominance of different bacteria were successfully 
promoted due to the increase of the C:N ratio by switching to a lower protein content diet 
and/or by the addition of a carbon source in the form of oligosaccharides (prebiotics) or 
non-prebiotic soluble carbohydrates (wheat starch or sucrose). 
Bacterial communities from the different samples collected showed differences 
among treatments that can be related to the prebiotic addition to the culture water. 
Intestinal content and hepatopancreas samples also showed significantly different 
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bacterial communities among treatments. Three explanations can be provided as to the 
effect of prebiotics added to the culture water on intestinal content and hepatopancreas 
bacteria: (1) prebiotics could be consumed by shrimp when biofloc particles were 
consumed or (2) prebiotics had an effect on biofloc particle bacteria which entered the 
shrimp through the consumption of biofloc particles, or (3) a combination of the two 
previous reasons. 
The bacterial community of the WSt treatment was not similar to the bacterial 
community of the other treatments, which can be attributed to the fact that WSt is a 
complex carbohydrate that is not as available to microorganisms as the oligosaccharides 
FOS, GOS, INU and MOS or the disaccharide SUC. Interestingly, although still different, 
with a 65.1% SC, the bacterial community of the biofloc particles with WSt addition 
were more closely related to the bacterial community of the biofloc particles collected 
during the ATr phase than to the rest of the treatments by a 47.6% SC, which supports the 
hypothesis of a lower carbon availability from WSt to bacteria than oligosaccharide 
prebiotics. Differences in bacterial communities of biofloc particles collected from the 
prebiotics treatments could be attributed to different chemical compositions of the 
prebiotics used in this study. 
The gills of crustaceans, such as crabs, shrimp and lobsters, play a critical role in 
respiration (Mangum, 1985), as well as in osmotic and ion regulation (Henry and 
Cameron, 1983; Henry, 1987). Bacteria injected into crabs and shrimp can be trapped and 
subsequently inactivated or degraded in the gills (Martin et al., 1993; Alday-Sanz et al., 
2002; Burgents et al., 2005) or externalized at the next molt (Martin et al., 2000). Thus, 
the crustacean gill is also important for immune defense against bacterial pathogens. 
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Interestingly, a prebiotic effect was observed on the bacterial composition of the gills of 
shrimp where prebiotics were added to the culture water as they have a bacterial 
composition not similar to the bacterial composition of shrimp gills sampled from the 
initial shrimp, during the ATr phase or from the SUC and WSt treatments.  
Similar results were obtained from bacterial communities present in the 
hepatopancreas samples of shrimp subjected to the different prebiotic treatments vs. WSt 
and INL or ATr samples. Even though a study has shown that bacterial richness and 
diversity of the hepatopancreas tissue remains relatively more stable than the bacterial 
community of the gut during gonadal development of Neocardina denticulata (Cheung et 
al., 2015), this current study showed that the bacteria community of shrimp 
hepatopancreas can be altered rather soon when prebiotics were added to the culture 
water. The discrepancy in results could be attributed to the particular conditions of this 
trial, i.e., the bacterial load in this study was expected to be higher due to the promotion 
of bacteria to control water quality and due to the zero-water exchange maintained in this 
study. The high bacterial load was more easily altered by the addition of prebiotics to the 
water. 
In conclusion, results from this study showed that:  
(1) Carbon from WSt was not as available to bacteria as oligosaccharides or the 
disaccharide used in this study and this was reflected in biofloc concentration and its 
bacteria profile. 
(2) Prebiotics and sucrose addition into the culture water altered the bacterial 
composition of biofloc particles and shrimp gills, hepatopancreas and intestinal contents. 
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(3) WSt did not have as much of an effect as prebiotics and sucrose on the 
bacterial composition of biofloc, shrimp gills, hepatopancreas and intestinal contents 
when it was added to the culture water. 
(4) No effect on shrimp production data or water quality was found in this study, 
which could be related to an external parameter such as underfeeding. 
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CHAPTER III 
EFFECT OF PREBIOTICS AND AN ESSENTIAL OIL BLEND ADDED TO THE 
FEEDS OF PACIFIC WHITE SHRIMP Litopenaeus vannamei ON BACTERIAL 
COMPOSITION OF BIOFLOC AND SHRIMP INTESTINE, GILLS AND 
HEPATOPANCREAS 
III.1 Introduction
Fisheries and aquaculture are important sources of food, nutrition, income and 
livelihoods for hundreds of millions of people around the world (FAO, 2016). In 2014, 
world per capita fish supply reached a new record of 20 kg mainly because of the 
dramatic growth in aquaculture production; whereas, capture fishery production has 
remained relatively static since the late 1980s. Global total aquaculture production in 
2014 were 73.8 million tons, of which 47.1 million tons were from inland waters and 
26.7 million tons were from marine waters (FAO, 2016). Crustacean production in 2014 
amounted to a total of 6.9 million tons with a value of US$ 36.2 billion, making them the 
second most valuable commodity of aquaculture, surpassed only by finfish (FAO, 2016). 
However, the success of shrimp aquaculture can be compromised due to reduced shrimp 
health, which is regulated by environment, and pathogen and host interactions (Gainza 
and Romero et al., 2017). The alteration of any of these factors or interactions can cause 
disease outbreaks, which lead to significant losses in the shrimp aquaculture industry 
(Luna et al., 2013). 
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Due to the detrimental effects of antibiotics and disinfectants on the environment 
and their risks to global public health (La Para et al., 2011; Wright, 2010; Su et al., 2017), 
prebiotics and essential oils have been proposed as alternatives to improve shrimp health 
and reduce the risk of disease outbreaks. In fish species, some studies have documented 
improvements in feed efficiency (FE) and nonspecific immune responses due to a dietary 
regimen of commercially available prebiotics of fish such as hybrid striped bass, Morone 
chrysops x M. saxatilis, with Grobiotic-A (Li and Gatlin 2004), rainbow trout, 
Oncorhynchus mykiss, with mannan-oligosaccharide (MOS) (Staykov et al. 2007) and 
Atlantic salmon, Salmo salar, with MOS, fructooligosaccharide (FOS) and 
galactooligosaccharide (GOS) (Grisdale-Helland et al. 2008). The effects of prebiotics 
also have been studied to a limited extent for crustacean aquaculture (Daniels and 
Hoseinifar, 2014; Merrifield and Ringø, 2014) with improvements in weight gain and 
feed efficiency ratio (FE) documented in shrimp (Zhou et al., 2007; Genc et al., 2007). 
Plant products present another alternative to antibiotics and disinfectants in 
aquaculture. The antibacterial efficacy of plant products such as essential oils, as well as 
their effect on nutrient utilization, growth and survival also have been evaluated with 
promising results in the aquaculture sector with fish and shrimp (Citarasu et al., 2006; 
Luo, 1997; Immanuel et al., 2004; Galina et al., 2009). 
A variety of prebiotics and essential oils have been evaluated as feed additives 
included in the feed of different cultured organism. However, no study on the effects that 
prebiotics or essential oils may have on shrimp production and on the bacterial 
community have been conducted on shrimp cultured under biofloc conditions. Therefore, 
the objective of this study was to evaluate the effects of prebiotics (fructooligosaccharide 
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(FOS), galactooligosaccharide (GOS), inulin (INU) and mannan-oligosaccharide (MOS)) 
and a commercially available essential oil blend (EOB) on bacterial profiles present in 
biofloc particles and Litopenaeus vannamei hepatopancreas, intestine and gills when 
these additives are provided to the shrimp through the diet. In addition, the effects of 
these additives on shrimp health and production as well as on water quality were 
assessed. 
III.2 Materials and methods
III.2.1 Experimental conditions
A 31-day trial (Trial II) was conducted at the trū® Shrimp Company experimental 
station located in Balaton, MN, USA to evaluate the effect of different prebiotics on 
shrimp production and bacterial composition of biofloc and shrimp hepatopancreas, gills 
and intestinal contents. Each tank (0.457 m x 0.457 m x 0.280 m) contained an 
independent heater, an automatic 48-h feeder, and two air stones. Tanks were filled to 20-
cm depth with artificial seawater of 28 g/L salinity, at 30.0 ± 1.0oC. Water lost due to 
evaporation was replaced weekly with reverse osmosis water. To maintain buffering 
capacity, sodium bicarbonate (NaHCO3) was added if alkalinity levels fell below 180 
mg/L. Application levels were determined using the following formula: 
NaHCO3 needed per tank (g) = ((deficiency in alkalinity (mg/L) / concentration of 
HCO3 in NaHCO3 (72.646 (%); 0.72646)) × tank volume (L)) / 1000 (mg/g) 
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All tanks were operated as zero-exchange Biofloc Technology (BFT) system. 
During the autotrophic phase (ATr; see Chapter I, subheading I.2), autotrophic bacteria 
were promoted and maintained from the initial day until Imhoff cone readings reached 3 
mL/L. Only during the ATr phase, all shrimp were fed with the same feed and fines 
formulated to contain 35% crude protein (CP) (as-fed basis) at a mean of 3.4 g/day per 
tank and 0.037 g/L, respectively. Heterotrophic phase (see Chapter I, subheading I.2) was 
promoted when Imhoff cone readings reached 3 mL/L. Only during heterotrophic phase, 
the total ammonia-nitrogen (TAN; NH3/NH4
+), nitrite (NO2
-) and nitrate (NO3
-) levels 
were maintained at <3, <5 and <100 mg/L, respectively, by giving the experimental and 
control diets formulated to contain 23% CP according to treatment-tank assignment. No 
source of carbon was added to the culture water other than that provided through the feed. 
III.2.2 Shrimp
Post-larvae weighing 0.003 g arrived at the experimental station from a 
commercial hatchery (Shrimp Improvement Systems, SIS, Inc, Islamorada, Florida, 
USA) and were acclimated to nursery tank conditions filled with artificial seawater of 
28.0 ± 0.5 g/L salinity, at 29.0 ± 1.0oC. Shrimp in nursery tanks were maintained as 
described for Trial I (Chapter II) and remained there until the experiment stocking date. 
Shrimp with no visual signs of disease or stress were collected and weighed. Shrimp 
weighing 2.08 ± 0.5 g, were stocked into each tank at a density of 20 shrimp/tank. Initial 
group weight was recorded and mean individual weight was calculated as well as initial 
biomass based on water volume of the experimental tanks (Table III.1). Mortality counts 
and weights were recorded and replaced with same size shrimp only during a 2-day 
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acclimation period. When the trial started, a small net was used to carefully check for 
mortalities and leftover feed without disturbing the living organisms. Mortalities were 
recorded and discarded.  
Table III.1. Initial shrimp group weight, biomass and 
individual shrimp weight for Trial II.1
Treatment2
Group 
weight  
(g/tank) 
Biomass 
(g/m3) 
 Individual 
mean weight 
(g) 
CTL 41.8 1,001.2 2.1 
FOS 43.2 1,029.9 2.2 
GOS 42.9 1,025.7 2.1 
INU 42.0 1,004.4 2.1 
MOS 38.2 913.5 2.0 
EOB 41.6 996.2 2.1 
WSt 41.4 992.0 2.1 
SUC 42.2 1,010.2 2.1 
PSE3 0.49 11.64 0.02 
1 Values are expressed as means per treatment.
2 CTL = control; EOB = essential oil blend; FOS = fructooligosaccharide; 
GOS = galactooligosaccharide; INU = inulin; MOS = mannan-
oligosaccharide; WSt = wheat starch; SUC = sucrose. 
3 PSE = pooled standard error of treatment means (n = 4). 
III.2.3 Feed and feeding management
Eight diets were used in Trial II and each diet was provided to shrimp according 
to its treatment. Higher protein content diet and fines were obtained from Trial I. To 
prepare the experimental diets, all dry ingredients of the reference diet were weighed and 
mixed in an industrial mixer for 15 min until achieving a completely homogenized 
mixture. Then, the dry mixture was divided into eight equal parts and each was mixed 
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with the experimental additives. Each batch was posteriorly blended with sodium 
hexametaphosphate and alginate (Table III.2) previously mixed with 150 mL of 
deionized water per kg of dry feed using a hand mixer (Sunbeam Products Inc., Milford, 
MA) until an appropriate mash consistency for extrusion was obtained. Fish and soybean 
oil were also added during this step. Extrusion was made using a meat chopper 
attachment (Model A-800, Hobart Corporation, Troy, OH, USA) fitted with a 3-mm die. 
Moist feed strands were dried on wire racks in a forced air oven at 35oC to a moisture 
content of 8-10%. After a 24-h drying period, feed was milled and sifted into the 
appropriate size for shrimp consumption, bagged, and stored at 4oC until used to feed the 
shrimp. Samples were also taken for analysis of proximate composition according to the 
AOAC (1990) procedures for dry matter, lipid, and ash contents and to the Dumas 
method (AOAC, 2005) for crude protein composition. Proximate composition of feed 
was performed in duplicate samples per diet. 
Formulation as well as ash, protein and lipid composition of each diet can be 
found in Table III.2. Fines were obtained by grinding the higher protein content diet and 
sieving to get particles between 0.595-0.420 mm. During the heterotrophic phase (day 0-
7), the higher protein content diet was loaded into the feeders and fines were added 
directly to the culture water as described in Table III.3. The lower protein content 
reference and experimental diets were loaded on the automatic feeders from day 5 until 
termination and no additional fines were added in order to increase the C:N ratio and to 
promote the dominance of heterotrophic bacteria. Based on previous experience, it was 
expected that, for this size, shrimp were going to grow linearly. A feed curve based on 
the number of shrimp, expected shrimp growth and FE was used to determine the 
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expected feed regimen offered to each tank (Expected feed regimen = shrimp count × 
Expected weight increase (g) × FE) (Table III.3). Each 48-h feeder was loaded every 
other day based on the expected feed regimen of 2 days with adjustments based on 
leftover feed and water quality. 
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Table III.2. Formulation (%) of the experimental diets used for Trial II with determined ash, protein 
and lipid proximate composition (g/kg). 
Experimental diets 
Ingredient (%) 
35% 
CP 
CTL FOS GOS INU MOS EOB WSt SUC 
Squid muscle meala 30.0 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 
Wheat starchb 28.8 41.8 41.8 41.8 41.8 41.8 41.8 41.8 41.8 
Fish mealc 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 
Soy protein isolatedd 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Dicalcium phosphateb 4.2 4.6 4.6 4.6 4.6 4.6 4.6 4.6 4.6 
Lecithin, dry, 95%c 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 
Diatomaceous earthe 3.8 3.7 0.9 0.9 0.9 0.9 0.9 0.9 0.9 
Cellulosef 3.2 3.2 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Calcium carbonatef 2.5 2.2 2.2 2.2 2.2 2.2 2.2 2.2 2.2 
Alginate (Manucol DM)g 2.0 2 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Potassium chloridef 1.9 2 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Magnesium oxideh 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 
Sodium hexametaphosphatef 1.0 1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Sodium chloridef 0.7 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 
Menhaden fish oilc 0.6 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 
Soybean oili 0.6 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 
Vit/Min premix r 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 
Cholesterola 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
DL-Methioninek 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
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Table III.2. Continued. 
Experimental diets 
Ingredient (%) 
35% 
CP 
CTL FOS GOS INU MOS EOB WSt SUC 
Fructooligosaccharidel 3.0 
Galactooligosaccharidem 3.0 
Inulinn 3.0 
Mannanoligossacharideo 3.0 
Essential oil blendp 3.0 
Wheat Starchb 3.0 
Sucroseq 3.0 
Proximate composition (g/kg, dry weight) 
Ash 131.4 173.8 150.0 143.6 150.7 151.6 168.6 148.8 147.4 
Protein 385.5 233.9 225.8 222.6 230.8 232.3 232.4 226.9 230.1 
Lipids 82.5  78.4 78.5 79.6 76.1 81.8 81.4 81.1 79.6 
a Zeigler Bros., Inc. Gardners, PA, USA 
b MP Biomedicals Santa Ana, CA, USA 
c ADM Co. Chicago, IL, USA 
d Solae LLC, St. Louis, MO, USA 
e Absorbent Products LTD 
f Fisher Scientific 
g FMC BioPolymer 
h Prince Agri Products 
i Consumer's Supply 
k Evonik Degussa Corporation  
l sc-FOS; Ingredion Incorporated, Indianapolis, IN, USA 
m GOS; Ingredion Incorporated, Indianapolis, IN, USA 
n INU; JeTsu Technology Limited, London, UK 
o Bio-MOS; Alltech, Nicolasville, KY, USA
p Regano EX, Ralco Nutrition, Marshall, MN, USA 
q Nash Finch Company, Minneapolis, MN, USA 
r Composition given in Appendix 
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Table III.3. Expected feed curve based on shrimp count, expected weight increase and 
feed efficiency with actual fines and feed provided for Trial II. 
Day 
Shrimp 
count 
Expected 
weight 
(g) 
Expected 
weight 
increase 
(g) 
FE 
Expected 
feed 
regimen 
(g) 
35% 
CP 
Fines 
(g) 
Feed 
protein 
(%) 
Actual 
feed 
provided 
(g) 
ACN 20 2.08 - 1.3 3.40 - 35.00 6.74 
ACN 20 2.21 0.13 1.2 3.34 - - - 
0 20 2.35 0.14 1.1 3.25 3.00 35.00 6.39 
1 20 2.50 0.15 1.0 3.14 - - - 
2 20 2.65 0.16 1.0 3.34 3.00 35.00 6.53 
3 20 2.82 0.17 0.9 3.19 - - - 
4 20 3.00 0.18 0.9 3.78 3.00 35.00 7.56 
5 20 3.21 0.21 0.9 3.78 - - - 
6 20 3.42 0.21 0.8 3.36 3.00 35.00 6.72 
7 20 3.63 0.21 0.8 3.36 - - - 
8 20 3.84 0.21 0.8 3.36 - 23.00 6.72 
9 20 4.05 0.21 0.8 3.36 - - - 
10 20 4.26 0.21 0.8 3.36 - 23.00 6.72 
11 20 4.47 0.21 0.8 3.36 - - - 
12 20 4.68 0.21 0.8 3.36 - 23.00 6.72 
13 20 4.89 0.21 0.8 3.36 - - - 
14 20 5.10 0.21 0.8 3.36 - 23.00 6.72 
15 20 5.31 0.21 0.8 3.36 - - - 
16 20 5.52 0.21 0.8 3.36 - 23.00 6.72 
17 20 5.73 0.21 0.8 3.36 - - - 
18 20 5.94 0.21 0.8 3.36 - 23.00 6.72 
19 20 6.15 0.21 0.8 3.36 - - - 
20 20 6.36 0.21 0.8 3.36 - 23.00 6.72 
21 20 6.57 0.21 0.8 3.36 - - - 
22 20 6.78 0.21 0.8 3.36 - 23.00 6.72 
23 20 6.99 0.21 0.8 3.36 - - - 
24 20 7.20 0.21 0.8 3.36 - 23.00 6.72 
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Table III.3. Continued. 
Day 
Shrimp 
count 
Expected 
weight 
(g) 
Expected 
weight 
increase 
(g) FE 
Expected 
feed 
regimen 
(g) 
Fines 
(g) 
Feed 
protein 
(%) 
Actual 
feed 
provided 
(g) 
25 20 7.41 0.21 0.8 3.36 - - - 
26 20 7.62 0.21 0.8 3.36 - 23.00 6.72 
27 20 7.83 0.21 0.8 3.36 - - - 
28 20 8.04 0.21 0.8 3.36 - 23.00 6.72 
29 20 8.25 0.21 0.8 3.36 - - - 
30 20 8.46 0.21 0.8 3.36 - 23.00 2.00 
31 20 8.67 0.21 0.8 0.00  - - TMN 
Expected feed regimen = shrimp count × expected weight increment × FE 
Feed provided = actual feed loaded on 48-h feeders with amount calculated for 2 days 
TMN = Termination 
ACN = Acclimation  
III.2.4 Experimental treatments
Prebiotics used in this study were short-chain fructooligosaccharide (sc-FOS 
(FOS in this manuscript); Ingredion Incorporated, Indianapolis, IN, USA), 
galactooligosaccharide (GOS; Ingredion Incorporated, Indianapolis, IN, USA), mannan-
oligosaccharide (Bio-MOS (MOS in this manuscript); Alltech, Nicolasville, KY, USA), 
Inulin (INU; JeTsu Technology Limited, London, UK). In addition to prebiotics, non-
prebiotic carbohydrates used in this study included wheat starch (WSt; MP Biomedicals 
Santa Ana, CA, USA), and sucrose (SUC; Table sugar). In addition, a commercially 
available essential oil blend (EOB; Regano® EX, Ralco Nutrition, Marshall, MN, USA), 
containing calcium carbonate, diatomaceous earth (flow agent), hemicellulose extract, a 
proprietary essential oil bled mixture and mineral oil, was evaluated. A 3% inclusion 
level of each additive was mixed into the diets prepared for Trial II, replacing 0.2% 
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cellulose and 2.8% diatomaceous earth (Table III.2). A low protein content diet with no 
additive inclusion was used as a reference diet for Trial II. Each treatment was randomly 
assigned to four tanks for a total of 32 tanks used in Trial II. 
III.2.5 Data acquisition and analyses
All data was acquired and analyzed as described in Chapter II, Section II.2.5 for 
Trial I with the following exceptions: 
(1) An initial hemolymph sample (INL) was collected on stocking day. 
(2) No biofloc sample collected from the autotrophic phase was available for 
proximate composition. 
(3) No initial sample or sample collected during the autotrophic phase was 
available for denaturing gradient gel electrophoresis of shrimp GT, HP or IC. 
III.2.6 DNA isolation and PCR
DNA was isolated and PCR was conducted as previously described in Chapter II, 
section II.2.6 for Trial I. 
III.2.7 Denaturing gradient gel electrophoresis
Denaturing gradient gel electrophoresis (DGGE) was performed as described for 
Trial I in Chapter II, Section II.2.7. 
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III.2.8 Calculations and statistical analyses
The responses utilized to compare treatments in this study as well as the statistical 
analyses were performed as described for Trial I in Chapter II, Section III.2.8. 
III.3 Results
Mean dissolved oxygen, temperature, salinity and pH values from daily 
observations are shown in Table III.4 per treatment. Final weight, weight gain, FE, 
survival, HSI or K score showed no significant differences among treatments (Table 
III.5). Total hemocyte count (THC) showed significant differences among treatments,
being higher in hemolymph of shrimp fed diets containing EOB or the prebiotics MOS, 
INU and GOS, and  lower in hemolymph of shrimp collected during the initial sampling. 
No significant differences were observed in mean biofloc concentration among any of the 
treatments evaluated (Figure III.1). Also, no significant differences were observed in total 
ammonia-nitrogen, nitrite, nitrate or alkalinity in the culture systems due to the various 
treatments (Tables III.6 and III.7). 
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Table III.4. Dissolved oxygen (mg/L), salinity (g/L), 
temperature (oC) and pH means results from daily 
observations during Trial II. 
Treatment 
Dissolved 
Oxygen 
(mg/L) 
Salinity 
(g/L) 
Temperature 
(oC) pH 
CTL 5.4 28.7 30.0 8.1 
FOS 5.3 28.8 29.9 8.2 
GOS 5.3 29.3 30.4 8.2 
INU 5.3 28.9 30.5 8.2 
MOS 5.2 28.9 30.8 8.1 
EOB 5.3 29.2 30.5 8.2 
WSt 5.4 28.9 29.8 8.1 
SUC 5.4 29.0 29.8 8.2 
PSE 0.02 0.05 0.11 0.02 
1 CTL = control reference; EOB = essential oil blend; FOS = 
fructooligosaccharide; GOS = galactooligosaccharide; INU = inulin; 
MOS = mannan-oligosaccharide; WSt = wheat starch; SUC = sucrose. 
2 PSE = pooled standard error of treatment means (n = 4). 
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Table III.5. Final weight, weight gain, feed efficiency and survival as well as 
K, HSI and THC of shrimp fed the control diet with no additive inclusion and 
the experimental diets containing prebiotics fructooligosaccharide, 
galactooligosaccharide, inulin or mannan-oligosaccharide or non-prebiotic 
carbohydrates wheat starch or sucrose or the essential oil blend at 3% dietary 
inclusion level used during Trial II.1
Treatment2 
Final 
weight 
(g) 
Weight 
gain 
(%) FE 
Survival 
(%) K HSI THC 
INL 1.33
b 
CTL 6.6 215.8 1.3 95.0 0.9 0.03 2.06
ab 
FOS 6.5 202.2 1.3 96.3 0.8 0.03 1.84ab 
GOS 6.1 186.6 1.5 97.5 0.8 0.04 2.25ab 
INU 6.3 199.9 1.4 98.8 0.8 0.03 2.81ab 
MOS 6.4 242.2 1.2 100.0 0.8 0.02 3.05a
EOB 6.6 216.7 1.3 96.3 0.8 0.04 3.10a
WSt 6.2 197.2 1.4 98.8 0.8 0.03 1.77ab 
SUC 6.7 217.6 1.3 96.3 0.9 0.04 1.79ab 
PSE3 0.06 4.97 0.02 0.59 0.01 0.002 0.15 
Anova 
(Pr > F) 
0.100 0.201 0.070 0.242 0.307 0.07 0.017 
1 Values represent means per treatment. 
2 INL = initial; CTL = control reference; FOS = fructooligosaccharide; GOS = 
galactooligosaccharide; INU = inulin; MOS = mannan-oligosaccharide; WSt = wheat starch; SUC 
= sucrose; EOB = essential oils blend. 
FE = feed efficiency; K = condition factor; HSI = hepatosomatic index; THC = total hemocyte 
count (107 cells/mL). 
3 PSE = pooled standard error of treatment means (final weight, weight gain, FE and survival: 
n=4; K, HSI and THC: n = 3). 
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Figure III.1. Mean biofloc levels (mL/L) of tanks subjected to dietary treatments with 3% 
inclusion of the prebiotics fructooligosaccharide, galactooligosaccharide, inulin or 
mannan-oligosaccharide or the non-prebiotic carbohydrates wheat starch or sucrose or the 
essential oil blend during Trial II.1,2  
1 Values are expressed as means with no significant differences (p ≤ 0.05) ± PSE (n = 4) of the weekly 
biofloc readings obtained from Imhoff cones. 
2 CTL = control reference; FOS = fructooligosaccharide; GOS = galactooligosaccharide; INU = inulin; 
MOS = mannan-oligosaccharide; EOB = essential oil blend; WSt = wheat starch; SUC = sucrose. 
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Table III.6. Mean values over time for total ammonia-nitrogen (TAN) and nitrite of 
tanks fed the control diet or the experimental diets containing prebiotics 
fructooligosaccharide, galactooligosaccharide, inulin or mannan-oligosaccharide 
or the non-prebiotic carbohydrates wheat starch or sucrose or the essential oil 
blend at 3% dietary inclusion level used during Trial II.1
Total Ammonia-Nitrogen Nitrites 
Treatment2 
Day 
3 
Day 
10 
Day 
17 
Day 
24 
Day 
3 
Day 
10 
Day 
17 
Day 
24 
CTL 1.33 1.25 0.17 1.29 0.20 0.22 0.10 0.13 
FOS 1.33 1.09 0.07 1.20 0.21 0.23 0.08 0.15 
GOS 1.43 1.10 0.10 0.96 0.23 0.24 0.10 0.12 
INU 1.30 0.81 0.10 1.14 0.16 0.17 0.10 0.15 
MOS 1.97 1.05 0.10 1.32 0.20 0.24 0.14 0.19 
EOB 1.10 0.72 0.07 1.33 0.15 0.15 0.09 0.17 
WSt 1.63 1.00 0.12 1.45 0.15 0.16 0.09 0.15 
SUC 1.10 0.72 0.09 1.70 0.11 0.15 0.08 0.18 
PSE3 0.10 0.01 0.01 0.08 0.01 0.01 0.01 0.01 
Anova 
(Pr>F) 
0.442 0.890 0.563 0.488 0.591 0.455 0.374 0.841 
1 Values represent treatment means of the weekly observations. 
2 CTL = control reference; FOS = fructooligosaccharide; GOS = galactooligosaccharide; INU = inulin; 
MOS = mannan-oligosaccharide; WSt = wheat starch; SUC = sucrose; EOB = essential oil blend. 
3 PSE = pooled standard error of treatment means (n = 4). 
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Table III.7. Mean values over time for total nitrate and alkalinity of tanks fed the 
control diet or the experimental diets containing prebiotics fructooligosaccharide, 
galactooligosaccharide, inulin or mannan-oligosaccharide or the non-prebiotic 
carbohydrates wheat starch or sucrose or the essential oil blend at 3% dietary 
inclusion level used during Trial II.1
Nitrates Alkalinity 
Treatment2 
Day 
3 
Day 
10 
Week 
17 
Week 
24 
Day 
3 
Day 
10 
Week 
17 
Week 
24 
CTL 35.40 14.21 25.19 22.17 164.67 144.50 162.75 193.50 
FOS 27.96 14.07 23.61 20.25 162.33 148.75 172.00 178.00 
GOS 30.94 15.42 23.19 23.80 172.00 156.50 170.50 178.25 
INU 54.06 11.43 19.15 17.98 159.33 147.50 174.50 188.25 
MOS 39.47 13.36 23.00 21.86 175.00 162.25 162.50 173.75 
EOB 48.79 13.36 19.08 18.75 164.67 150.25 158.50 173.50 
WSt 36.04 13.32 21.83 21.76 167.00 147.25 157.25 181.50 
SUC 51.43 14.56 19.30 21.62 164.00 154.25 174.00 183.00 
PSE3 7.09 0.51 0.82 0.99 2.65 2.73 2.81 2.79 
Anova 
(Pr>F) 
0.986 0.743 0.432 0.890 0.901 0.816 0.643 0.650 
1 Values represent treatment means of the weekly observations. 
2 CTL = control reference; FOS = fructooligosaccharide; GOS = galactooligosaccharide; INU = inulin; 
MOS = mannan-oligosaccharide; WSt = wheat starch; SUC = sucrose; EOB = essential oil blend. 
3 PSE = pooled standard error of treatment means (n = 4). 
Significant (p ≤ 0.05) differences were observed in ash and protein composition 
of biofloc samples collected at the end of Trial II (Table III.8). Ash content was higher (p 
≤ 0.05) in biofloc of treatments where shrimp were fed diets containing INU or SUC and 
lower (p ≤ 0.05) in biofloc of treatments where shrimp were fed diets containing GOS, 
MOS or the CTL diet. Protein content was higher (p ≤ 0.05) in biofloc of the CTL, GOS, 
and MOS treatments and lower (p ≤ 0.05) in the INU and SUC treatments. No differences 
(p ≤ 0.05) were observed for lipid composition of biofloc collected during Trial II (Table 
III.8).
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Differences (p ≤ 0.05) were observed in ash contents of shrimp muscle having the 
higher ash content in the GOS treatment and the lowest ash content in the SUC, CTL and 
FOS treatments (Table III.8). No significant differences were observed in protein or lipid 
content of shrimp muscle in Trial II (Table III.8). 
Table III.8. Ash, protein and lipid content of biofloc and muscle of 
shrimp fed the control diet with no additive inclusion and the 
experimental diets with prebiotics fructooligosaccharide, 
galactooligosaccharide, inulin or mannan-oligosaccharide or non-
prebiotic carbohydrates wheat starch or sucrose or the essential oil 
blend at 3% dietary inclusion level used during Trial II. 
Biofloc Muscle 
Treatment1,3 Ash Protein Lipids Ash Protein Lipids 
CTL 78.5bc 8.0ab 5.4 6.7b 92.9 15.1 
FOS 79.4bc 7.4ab 3.8 6.4b 90.6 15.0 
GOS 76.7c 9.5a 5.8 8.0a 97.4 14.6 
INU 82.5a 5.5b 4.1 7.1ba 84.9 14.0 
MOS 77.5c 9.3a 6.5 6.9ba 94.6 14.0 
EOB 78.6bc 7.6ab 4.7 7.1ba 97.8 15.1 
WSt 79.3bc 7.8ab 3.9 7.2ba 97.4 14.0 
SUC 81.2ab 6.5b 5.7 6.1b 93.3 14.6 
PSE2 0.41 0.30 0.41 0.13 1.27 0.18 
Anova 
(Pr>F) 
0.0001 0.001 0.708 0.002 0.159 0.473 
1 CTL = control reference; FOS = fructooligosaccharide; GOS = 
galactooligosaccharide; INU = inulin; MOS = mannan-oligosaccharide; WSt = 
wheat starch; SUC = sucrose; EOB = essential oil blend. 
2 PSE = pooled standard error of treatment means (n = 4). Mean in columns and 
with the same superscript letter are not significantly different (p ≤ 0.05). 
3 Proximate composition analyses of ash and lipids were performed with no 
duplicate sample because not enough sample was available. 
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In terms of bacterial community present in the biofloc particles (Figure III.2), the 
bacterial community present during the ATr phase was not similar to the rest of the 
bacterial communities sampled. The bacterial communities present in the CTL and WSt 
treatments were very similar to each other and not similar to the rest of the bacterial 
communities sampled. The bacterial community present in the SUC treatment was not 
similar to the rest of the bacterial communities sampled; whereas those of the treatments 
where MOS and FOS were added were very similar to each other and to the GOS and 
INU treatments and somewhat similar to that of the EOB treatment. 
Gills tissue bacterial communities present in the WSt and SUC treatments were 
very similar to each other; whereas they were determined to be similar to the CTL 
treatment (Figure III.3). Communities in the WSt, SUC and CTL treatments were 
somewhat similar to the rest of the treatments. Bacterial communities present in the FOS, 
GOS, INU and MOS treatments were very similar to each other, and all of them together 
were only similar to the bacterial community with the EOB addition. 
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Figure III.2. Dendrogram of the biofloc particles (BFP) bacterial communities collected during the autotrophic phase (ATr) or 
during termination from tanks in which shrimp were fed diets with no additive inclusion (CTL; control) or diets containing 
fructooligosaccharide (FOS), galactooligosaccharide (GOS), inulin (INU), mannan-oligosaccharide (MOS), wheat starch 
(WSt), sucrose (SUC) or essential oil blend (EOB) of Trial II. 
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Figure III.3. Dendrogram of the gills tissue (GT) bacterial communities sampled during the autotrophic phase (ATr) or during 
termination from shrimp fed diet with no additive inclusion (CTL; control) or diets containing fructooligosaccharide (FOS), 
galactooligosaccharide (GOS), inulin (INU), mannan-oligosaccharide (MOS), wheat starch (WSt), sucrose (SUC) or essential 
oil blend (EOB) of Trial II. 
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Hepatopancreas bacterial communities in the CTL and FOS treatments were 
likely the same or identical to each other and both bacterial communities were not similar 
to the bacterial communities present in the rest of the samples (Figure III.4). 
Additionally, the bacterial community of the GOS treatment was not similar to the 
bacterial communities of the other samples. Bacterial communities of the MOS and EOB 
treatments were likely the same or identical to each other and they were very similar to 
the WSt treatment; whereas those of the MOS, EOB and WSt treatments were only 
similar to the INU and SUC treatments. Also, the bacterial communities of the SUC and 
INU treatments were likely the same or identical to each other and similar to the bacterial 
communities of the WSt, EOB and MOS treatments. 
Intestinal contents bacterial communities present in the INU, MOS, FOS WSt and 
SUC treatments were very similar to each other, similar to the GOS treatment and 
somewhat similar to the CTL and EOB treatments (Figure III.5). In addition, bacterial 
communities in the CTL and EOB treatments were very similar to each other and 
somewhat similar to the rest of the samples. 
A comparison of different samples collected from the CTL treatment was 
performed and is shown in Figure III.6. Bacterial communities of the BFP and HP were 
somewhat similar to each other but not similar to the bacterial communities of the GT 
and IC. Bacterial communities of the GT and IC were not similar to each other. 
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Figure III.4. Dendrogram of the hepatopancreas (HP) bacterial communities sampled during the autotrophic phase (ATr) or 
during termination from shrimp fed diet with no additive inclusion (CTL; control) or diets containing fructooligosaccharide 
(FOS), galactooligosaccharide (GOS), inulin (INU), mannan-oligosaccharide (MOS), wheat starch (WSt), sucrose (SUC) or 
essential oil blend (EOB) of Trial II. 
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Figure III.5. Dendrogram of the intestinal contents (IC) bacterial communities sampled during the autotrophic phase (ATr) or 
during termination from shrimp fed diet with no additive inclusion (CTL; control) or diets containing fructooligosaccharide 
(FOS), galactooligosaccharide (GOS),  inulin (INU), mannan-oligosaccharide (MOS), wheat starch (WSt), sucrose (SUC) or 
essential oil blend (EOB) of Trial II. 
Figure III.6. Dendrogram of the bacterial communities sampled from the control (CTL) treatment of biofloc particles (BFP), 
gills tissue (GT), hepatopancreas (HP) and intestinal contents (IC) of Trial II. 
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III.4 Discussion
Experimental feed additives were included to the diets of L. vannamei to examine 
their efficacy on shrimp health and production parameters, water quality and bacterial 
content of biofloc and shrimp gills, hepatopancreas, and intestinal contents. Diets were 
prepared replacing cellulose and diatomaceous earth at levels that did not affect shrimp 
digestibility and growth or survival (Borrer, 1989). 
Final weight, weight gain, FE, survival, HSI or K showed no significant 
differences among treatments. These findings are in agreement with other crustacean 
studies, e.g., Bio-MOS® in the diet of western king prawn Penaeus latisulcatus juveniles 
(Van Hai et al., 2009), sc-FOS in the diet of Pacific white shrimp L. vannamei (Li et al., 
2007) and inulin in the diet of Indian white, Fenneropenaeus indicus shrimp larvae and 
postlarvae (Hoseinifar et al., 2010). Other studies have shown production enhancement 
due to the use of prebiotics, e.g., the addition of MOS in the diet of P. semisulcatus (Genc 
et al., 2007) and sc-FOS in the diet for L. vannamei (Zhou et al., 2007). The lack of effect 
of the prebiotics on production data in Trial II could be related to the lack of a source of 
stress or a pathogen during the experiment and to the higher growth rate of smaller 
shrimp used in the studies where an effect on production performances was observed 
(Genc et al., 2007; Zhou et al., 2007). 
Immunostimulants have been proposed as a suitable alternative to the use of 
antibiotics or growth promoters (Reikel et al., 2007). In fact, it has been proven that diets 
supplemented with immunostimulants confer considerable benefits to shrimp by boosting 
their immune system (Reid, 2008).  Hemocytes play an important role in antibacterial 
activity of crustaceans (Chisholm and Smith, 1995). Although the hemocyte count varies 
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among crustacean species and is known to be affected by a variety of factors such as 
infection and environmental stress, the THC of circulating hemocytes in crustaceans 
correlates well with the health condition of the shrimp and its ability to resist pathogens 
(Le Moullac et al., 1998; Le Moullac and Hanner, 2000). In Trial II, THC showed 
significant differences, with the highest concentration of hemocytes in hemolymph of 
shrimp fed diets containing EOB, MOS, INU and GOS and the lower hemocyte count 
was found in hemolymph of shrimp collected during the initial sampling. An increase in 
the THC has been observed in shrimp fed herbs (Wu et al, 2017; Bindhu et al., 2014) and 
other immunostimulants such as β-glucan for 3 days (Thanardkit et al., 2002) and 28 days 
(Chotikachinda et al., 2008; Srithunyalucksana et al., 2005). The increase in THC caused 
by these additives is a promising result that needs to be evaluated in shrimp subjected to a 
stressor or a disease challenge to confirm an enhancement in shrimp production 
performance due to improvement in health and disease resistance. 
Unlike in Trial I, no significant differences were observed in mean biofloc 
concentration among any of the treatments evaluated. This lack of difference is likely 
because shrimp were readily consuming the feed provided which reduced the loss of 
additives to the water. However, an effect in the bacterial composition was observed in 
biofloc particles related to treatments and will be discussed later. 
No significant differences were observed in total ammonia-nitrogen, nitrite, 
nitrate or alkalinity of water from the various treatments. Previous studies of prebiotics 
added to the diet of shrimp had much smaller inclusion levels than those used in the 
current study. The reason for the high dietary inclusion level of prebiotic in Trial II was 
to check for a possible effect on water quality parameters as affected by bacteria present 
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in biofloc particles that could possibly be enhanced by dietary prebiotics. The drastic 
reduction of ammonia and nitrites throughout the experiment could be related to the high 
inclusion of carbohydrate in the experimental diets. A smaller dietary inclusion level of 
carbohydrate sources should be evaluated to confirm an effect on water quality when 
prebiotics are supplemented in the shrimp diet. 
Lipid and protein contents were rather low in all bioflocs while ash was 
consistently high in all treatments. Although shrimp might utilized to some extent the 
nutrients provided by biofloc, it is obvious that the majority of their nutrient requirements 
were supplied by the artificial feed. Significant differences were observed in ash and 
protein composition of biofloc samples collected at the end of Trial II. Ash content was 
higher in biofloc of treatments containing INU or SUC and significantly lower for diets 
containing GOS, MOS and the CTL reference. In contrast, protein content was higher in 
biofloc of the CTL, GOS, and MOS. The effect of the dietary treatments on biofloc 
proximate composition could be related to the differences in biofloc bacterial 
composition. Bacterial identification in biofloc could provide further information to relate 
bacterial composition to diet nutrient availability of biofloc particles. 
Significantly higher ash content was found in shrimp muscle of the GOS 
treatment and lower ash content was found in the shrimp muscle of the SUC, CTL and 
FOS treatments. No significant differences were observed in protein or lipid content of 
shrimp muscle, which is in agreement with other studies analyzing muscle composition 
of shrimp fed diets with prebiotics (Aktaş et al., 2014). However, others have reported 
significant differences in shrimp whole-body protein composition with the addition of 
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prebiotics to the diet (Genc et al., 2007). More studies need to be developed to further 
examine the effect that prebiotics may have on nutrient composition of shrimp.  
Bacterial communities showed differences among treatments related to the 
prebiotic dietary inclusion and were very similar to results obtained in Trial I. Most 
studies have evaluated the effect that prebiotics have on the gastrointestinal tract of the 
animal being investigated, however, this current study showed that an effect of prebiotics 
and the EOB was also be observed in bacterial communities present in other shrimp 
tissues and organs as well as in biofloc particles of the shrimp culture water. The close 
relation between biofloc, shrimp and nutrient recycling that exists in a zero-exchange, 
BFT shrimp culture could explain the effect that different prebiotics have on different 
tissues of the organisms and in biofloc particles even when the additives are introduced to 
the culture system through the shrimp diet. 
In addition, a comparison of the bacterial community of the different samples 
collected for the CTL treatment was performed. Interestingly, bacterial communities of 
the BFP and HP were somewhat similar to each other and not similar to the bacterial 
communities of the GT and IC.  Bacterial communities of the GT and IC were not similar 
to each other. The differences in communities of different samples from the same 
treatment could be related to the different functions and environments of the tissues 
sampled. Differences in bacterial communities of different shrimp tissues are in 
agreement with previous studies. For example, a comparison between the hepatopancreas 
and gut microbiota of Neocaridina denticulate revealed that bacteria from the phylum 
Bacteroidetes were more represented in the hepatopancreas, while bacteria from the 
phylum Firmicutes were more represented in the foregut and intestine samples (Cheung 
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et al., 2015).  The authors explained these differences in relation to the different activities 
carried out by these organs, i.e., higher cellulolytic activity in the hepatopancreas, while a 
higher proteolytic activity in the intestine. 
In summary, results obtained from this study show the following: 
(1) Prebiotics and the essential oil blend changed the bacterial composition of 
biofloc particles and shrimp gills, hepatopancreas and intestinal contents when they were 
included in the shrimp diet. 
(2) The essential oil blend appeared to improve shrimp health and promoted a 
potentially higher resistance to pathogens as observed by the higher THC. 
(3) Bacterial flora differences among hepatopancreas, intestinal contents, gills and 
biofloc particles could be related to their different functions and environments. 
(4) Even though a higher growth was observed in Trial II than Trial I, no effect of 
the additives was observed on water quality or shrimp growth. 
(5) Identification of bacteria present in biofloc particles, shrimp gills, 
hepatopancreas, and intestine will provide further insights regarding the effects of the 
different additives tested. 
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CHAPTER IV 
EFFECT OF DIETARY INCLUSIONS OF PREBIOTICS AND ORGANIC ACID 
SALTS ADDED TO THE FEEDS OF PACIFIC WHITE SHRIMP Litopenaeus 
vannamei ON BACTERIAL COMPOSITION OF BIOFLOC AND SHRIMP 
INTESTINE, GILLS AND HEPATOPANCREAS 
 
IV.1 Introduction 
Disease outbreaks, among other things, have heavily impacted shrimp production; 
most recently with early mortality syndrome in Asia and America (TWB, 2013). These 
outbreaks provide a warning to rapidly expanding aquaculture sectors, such as shrimp 
aquaculture, of the importance of disease management and adoption of best practices 
(Bondad-Reantaso et al., 2005). 
Prebiotics have been proposed as an alternative to the use of antibiotics and 
disinfectants in aquaculture. The effect of different prebiotics have been studied to a 
limited extent in crustacean aquaculture (Daniels and Hoseinifar, 2014; Merrifield and 
Ringø, 2014). Studies conducted to evaluate the efficacy of some prebiotics in shrimp 
culture found improvements in weight gain and feed efficiency (FE) (Zhou et al., 2007; 
Genc et al., 2007).  
Another potential alternative to the detrimental use of antibiotics is the group of 
additives known as organic acids which have been receiving increasing attention due to 
their strong antibacterial and prophylactic properties against various pathogenic bacteria 
(da Silva et al., 2013; Defoirdt et al., 2006; Ng and Koh, 2011). Currently, there is an 
increasing tendency towards using organic acids in commercial aquafeeds both for 
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controlling disease and enhancing growth performance. Additionally, organic acids are 
commonly known as safe compounds that regularly contain one or more carboxyl groups 
(–COOH) and exhibit antibacterial properties (Defoirdt et al., 2009) and are generally 
composed of short-chain fatty acids (C1-C7), volatile fatty acids or weak carboxylic 
acids. Research has been done using organic acids in aquaculture organisms with 
promising results on fish and shrimp production performance and as immune enhancers. 
For example, it has been reported that the use of organic acids, their salts or mixtures can 
improve growth, feed utilization and disease resistance of several fish and shrimp species 
(Castillo et al., 2014; Ng and Koh, 2011, Ringø, 1991; da Silva et al., 2013; Romano et 
al., 2015; Lückstädt, 2008; Baruah et al., 2007; Hossain et al., 2007). 
Organic acids have been shown to have a direct bactericidal effect resulting from 
a pH decrease within bacterial cells (Ng et al., 2009b; Malicki et al., 2004; Freitag, 2007). 
These acids also may reduce the gastrointestinal pH thereby inhibiting the growth of 
pathogenic gram-negative bacteria (Luckstadt, 2008). The main antibacterial activity of 
organic acids is attributed to altering the cell cytoplasm pH of bacteria thereby inhibiting 
bacteria sensitive to such changes (Booth and Stratford, 2003). The antibacterial 
properties of organic acid salts, alone or in combination with organic acids or other food 
additives, has been examined and reported (Ukuku et al., 2005; Buchanan et al., 1993; 
Shelef and Addala, 1994; Stekelenburg and Kant-Muermans, 2001). However, no study 
has been developed on the effect prebiotics or organic acid salts added to the shrimp diet 
have on shrimp production and microbiology of biofloc, shrimp gills, hepatopancreas, 
and intestinal contents when cultured using a Biofloc Technology system. Therefore, the 
objective of this study was to evaluate the effects of the prebiotics fructooligosaccharide 
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(FOS) and galactooligosaccharide (GOS) at two dietary inclusion levels (1.5 and 3%) as 
well as the effects of the organic acids sodium acetate (SA), sodium lactate (SL) and 
sodium propionate (SP) at two dietary inclusion levels (0.75 and 1.5%) on bacterial 
profiles in biofloc particles and Litopenaeus vannamei hepatopancreas, intestine and gills. 
In addition, effects of these additives on shrimp production and water quality were 
assessed. 
 
IV.2 Materials and methods 
 
IV.2.1 Experimental conditions  
A 26-day trial (Trial III) was conducted in the trū® Shrimp Company 
experimental station located in Balaton, MN, USA to evaluate the effect of different 
organic acid salts and prebiotics on shrimp production and bacterial composition of 
biofloc and shrimp hepatopancreas, gills and intestinal contents. Thirty-six tanks (0.457 
m × 0.457 m × 0.280 m) containing an independent heater, an automatic 48-h feeder, and 
two air stones were used in this trial. Tanks were filled to 20-cm depth with artificial 
seawater of 28 g/L salinity and maintained at 30.0 ± 1.0oC. Sodium bicarbonate 
(NaHCO3) was added to maintain buffering capacity, if alkalinity levels fell below 180 
mg/L. Application levels were determined using the following formula: 
 
NaHCO3 needed per tank (g) = ((deficiency in alkalinity (mg/L) / concentration of 
HCO3 in NaHCO3 (72.646 (%); 0.72646)) × tank volume (L)) / 1000 (mg/g) 
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Water lost due to evaporation was replaced weekly with reverse osmosis water to 
maintain salinity at 28 g/L. All tanks were operated as zero-exchange BFT system. 
During the autotrophic phase (ATr; see Chapter I, subheading I.2), autotrophic bacteria 
were promoted and maintained from the initial day until Imhoff cone readings reached 3 
mL/L.  Only during the autotrophic phase, a nitrifying bacteria inoculum (Turbo Start 
900, FritzZyme, Mezquite, TX, USA) was added to the culture water according to 
manufacturer recommendations and shrimp were fed with pellets and fines formulated to 
containing 35% crude protein (CP) (as-fed basis) at a mean of 3.33 g/day per tank and 
0.037 g/L, respectively. Heterotrophic phase (see Chapter I, subheading I.2) was 
promoted when Imhoff cone readings reached 3 mL/L. Only during heterotrophic phase, 
total ammonia-nitrogen (TAN; NH3/NH4
+), nitrite (NO2
-) and nitrate (NO3
-) levels were 
maintained at <3, <5 and <100 mg/L, respectively, by feeding the experimental diets 
formulated to contain a lower protein content (23% CP) to each tank according to its 
treatment. 
IV.2.2 Shrimp
Post-larvae weighing 0.003 g arrived at the experimental station from a 
commercial hatchery (Shrimp Improvement Systems, SIS, Inc, Islamorada, Florida, 
USA) and were acclimated to nursery tanks conditions filled with artificial seawater of 
28.0 ± 0.5 g/L salinity, at 29.0 ± 1.0oC. Shrimp remained there until the experiment 
stocking date and were maintained as defined for Trial I (Chapter II). Shrimp with no 
visual signs of disease or stress were collected from the nursery tanks and were 
individually weighed. Shrimp weighing 3.5 ± 0.5 g were stocked into each tank at a 
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density of 325 shrimp/m3. Only the initial group weight was recorded and mean 
individual weight was calculated as well as the initial biomass based on the water volume 
of the experimental tanks (g/m3) (Table IV.1). Mortality counts and weights were 
recorded and replaced with the same size shrimp only during a 2-day acclimation period. 
When the trial was started, a small net was used to carefully check for mortalities and 
leftover feed without disturbing the living organisms. Mortalities were recorded and 
discarded.  
Table IV.1. Initial shrimp group weight, biomass, 
and individual shrimp weight for Trial III.1
Treatment2 
Initial 
group 
weight  
(g/tank) 
Initial 
biomass 
(g/m3) 
 Initial 
individual 
weight (g) 
CTL 68.2 1631.7 3.6 
FOS1.5 67.7 1620.7 3.6 
FOS3.0 65.9 1577.4 3.5 
GOS1.5 64.3 1540.3 3.4 
GOS3.0 64.6 1547.6 3.4 
SA0.75 67.2 1607.6 3.5 
SA1.5 65.0 1555.3 3.4 
SL0.75 65.6 1569.3 3.5 
SL1.5 66.6 1593.3 3.5 
SP0.75 64.3 1540.0 3.4 
SP1.5 65.1 1558.8 3.4 
PSE3 0.45 10.85 0.02 
1 Values represent treatment means. 
2 CTL = control reference; FOS1.5 = 1.5% fructooligosaccharide; 
FOS3.0 = 3% fructooligosaccharide; GOS1.5 = 1.5% 
galactooligosaccharide; GOS3.0 = 3% galactooligosaccharide; SA0.75 
= 0.75% sodium acetate; SA1.5 = 1.5% sodium acetate; SL0.75 = 
0.75% sodium lactate; SL1.5 = 1.5% sodium lactate; SP0.75 = 0.75% 
sodium propionate; SP1.5 = 1.5% sodium propionate. 
3 PSE = pooled standard error of treatment means (n = 3). 
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IV.2.3 Feed and feeding management 
Shrimp in Trial III were fed a high-protein diet during acclimation and the first 5 
days of the trial. Following this period, experimental diets formulated to contain a lower 
protein content were fed to promote heterotrophic bacteria dominance. The higher protein 
content diet and fines were the same as used for Trial I. Experimental diets containing the 
prebiotics fructooligosaccharide (FOS) and galactooligosaccharide (GOS) at 3% dietary 
inclusion level were the same used in Trial II. The remaining diets used were prepared 2 
weeks before shrimp were stocked in the experimental tanks for Trial III. To prepare the 
diets, all dry ingredients of the reference diet were weighed and mixed in an industrial 
mixer for 15 min until a completely homogenized mixture was achieved. Next, the dry 
mixture was divided into eight equal parts and each was mixed with the experimental 
additives. Each batch was posteriorly blended with sodium hexametaphosphate and 
alginate (Table IV.2) previously mixed with 150 mL of deionized water per kg of dry 
feed using a hand mixer (Sunbeam Products Inc., Milford, MA) until an appropriate mash 
consistency was obtained for extrusion. Fish and soybean oil were also added during this 
step. Extrusion was made using a meat chopper attachment (Model A-800, Hobart 
Corporation, Troy, OH, USA) fitted with a 3-mm die. Moist feed strands were dried on 
wire racks in a forced air oven at 35oC to a moisture content of 8-10%. After a 24-h 
drying period, feed was milled and sifted into the appropriate size for shrimp 
consumption, bagged, and stored at 4oC until used. Proximate composition of the diets 
was analyzed according to the AOAC (1990) procedures for dry matter, lipid, and ash 
contents and the Dumas method (AOAC, 2005) for crude protein composition. Proximate 
composition of feed was performed in duplicate samples. 
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Formulation of the high protein diet, as well as the experimental diets containing 
the additives can be found in Table IV.2. Fines were obtained by grinding the higher 
protein diet. From day 0-5 of the experiment, the high protein diet was provided along 
with fines obtained from the same diet as shown in Table IV.3. The experimental diets 
formulated to have a lower protein content were fed from day 6 until termination in order 
to increase the C:N ratio and promote the dominance of heterotrophic bacteria. Based on 
previous experience, it was expected that, for this size, shrimp were going to grow 
linearly. A feed curve based on number of shrimp, expected shrimp growth and FE was 
used to determine the expected feed regimen offered to each tank (Expected feed regimen 
= shrimp count × Expected weight increment (g) × FE) (Table IV.3). Each 48-h feeder 
was loaded every other day based on the expected feed regimen of 2 days with 
adjustments based on leftover feed, water quality and mortalities. 
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Table IV.2. Formulation (%) of the experimental diets used for Trial III with determined ash, protein and lipid 
composition (g/kg). 
Experimental diets 
Ingredient 
35% 
CP 
CTL 
FOS 
1.5 
FOS 
3.0 
GOS 
1.5 
GOS 
3.0 
SA 
0.75 
SA 
1.5 
SL 
0.75 
SL 
1.5 
SP 
0.75 
SP 
1.5 
Squid muscle meala 30.0 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 21.7 
Wheat starchb 28.75 43.58 43.58 43.58 43.58 43.58 43.58 43.58 43.58 43.58 43.58 43.58 
Fish mealc 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 
Soy protein isolated 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Dicalcium 
phosphateb
4.2 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 
Lecithin, dry, 95%c 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 
Diatomaceous earthe 3.8 3.7 2.2 0.9 2.2 0.9 3.0 2.2 3.0 2.2 3.0 2.2 
Cellulosef 3.2 3.2 3.2 3.0 3.2 3.0 3.2 3.2 3.2 3.2 3.2 3.2 
Calcium carbonatef 2.5 1.37 1.37 1.37 1.37 1.37 1.37 1.37 1.37 1.37 1.37 1.37 
Alginate (Manucol 
DM)g 
2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Potassium chloridef 1.9 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Magnesium oxideh 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 
Sodium 
hexametaphosphatef 
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Sodium chloridef 0.7 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 
Menhaden fish oilc 0.6 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 
Soybean oili 0.6 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 
Vit/Min premixr 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 1.25 
Cholesterola 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
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Table IV.2. Continued. 
Experimental diets 
Ingredient 
35% 
CP 
CTL 
FOS 
1.5 
FOS 
3.0 
GOS 
1.5 
GOS 
3.0 
SA 
0.75 
SA 
1.5 
SL 
0.75 
SL 
1.5 
SP 
0.75 
SP 
1.5 
DL-Methionine
k 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Fructo-
oligosaccharidel
1.5 3.0 
Galacto-
oligosaccharidem 
1.5 3.0 
Sodium acetates 0.75 1.5 
Sodium lactatet 0.75 1.5 
Sodium propionateu 0.75 1.5 
Ash 131.4 173.8 164.3 150.0 159.1 143.6 175.8 172.3 172.7 170.7 172.7 163.5 
Protein 385.5 233.9 235.7 225.8 230.9 222.6 235.8 232.2 228.5 235.2 229.4 234.1 
Lipids 82.5  78.4 85.7 78.5 82.1 79.6 82.0 85.4 79.8 87.6 90.7 83.4 
a Zeigler Bros., Inc. Gardners, PA, USA 
b MP Biomedicals Santa Ana, CA, USA 
c ADM Co. Chicago, IL, USA 
d Solae LLC, St. Louis, MO, USA 
e Absorbent Products LTD 
f Fisher Scientific 
g FMC BioPolymer 
h Prince Agri Products 
i Consumer's Supply 
k Evonik Degussa Corporation  
l sc-FOS; Ingredion Incorporated, Indianapolis, IN, USA 
m GOS; Ingredion Incorporated, Indianapolis, IN, USA 
n INU; JeTsu Technology Limited, London, UK 
o Bio-MOS; Alltech, Nicolasville, KY, USA
p Regano EX, Ralco Nutrition, Marshall, MN, USA 
q Nash Finch Company, Minneapolis, MN, USA 
r Composition given in Appendix 
s BeanTown Chemical, Hudson, NH, USA 
t ACROS Organics, New Jersey, USA 
u Alfa Aesar, Tewksbury, MA, USA 
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Table IV.3. Expected feed curve based on shrimp count, expected weight increase and 
feed efficiency with actual fines and feed provided for Trial III. 
Day 
Shrimp 
count 
Expected 
weight 
(g) 
Expected 
weight 
increment 
(g) FE 
Expected 
feed 
regimen 
(g) 
35% 
CP 
Fines 
(g) 
Feed 
protein 
% 
Actual 
feed 
provided 
(g) 
ACN 19 3.00 - 0.8 3.80 - 35 5 
ACN 19 3.25 0.25 0.8 3.80 - - - 
0 19 3.50 0.25 1.3 6.18 3.0 35 12 
1 19 3.75 0.25 1.3 6.18 3.0 - - 
2 19 4.00 0.25 1.2 5.70 3.0 35 11 
3 19 4.25 0.25 1.2 5.70 3.0 - - 
4 19 4.50 0.25 1.1 5.23 3.0 35 10 
5 19 4.75 0.25 1.1 5.23 - - - 
6 19 5.00 0.25 1.0 4.75 - 23 9 
7 19 5.25 0.25 1.0 4.75 - - - 
8 19 5.50 0.25 0.9 4.23 - 23 8 
9 19 5.75 0.25 0.9 4.23 - - - 
10 19 6.00 0.25 0.8 3.80 - 23 7 
11 19 6.25 0.25 0.8 3.80 - - - 
12 19 6.50 0.25 0.8 3.80 - 23 7 
13 19 6.75 0.25 0.8 3.80 - - - 
14 19 7.00 0.25 0.8 3.80 - 23 7 
15 19 7.25 0.25 0.8 3.80 - - - 
16 19 7.50 0.25 0.8 3.80 - 23 7 
17 19 7.75 0.25 0.8 3.80 - - - 
18 19 8.00 0.25 0.8 3.80 - 23 7 
19 19 8.25 0.25 0.8 3.80 - - - 
20 19 8.50 0.25 0.8 3.80 - 23 7 
21 19 8.75 0.25 0.8 3.80 - - - 
22 19 9.00 0.25 0.8 3.80 - 23 6 
23 19 9.25 0.25 0.8 3.80 - - - 
24 19 9.50 0.25 0.8 3.80 - 23 6 
25 19 9.75 0.25 0.8 3.80 - 23 2 
26 19 10 0.25 1.8 0.00 - - TMN 
ACN = acclimation period; FE = feed efficiency; TMN = termination 
Expected feed regimen = shrimp count × expected weight increment × FE 
Feed provided = actual feed loaded on 48-h feeders with amount calculated for 2 days 
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IV.2.4 Experimental treatments 
A control diet was used in which no additive was included in the diet. Prebiotics 
used in this study were fructooligosaccharide (sc-FOS; Ingredion Incorporated, 
Indianapolis, IN, USA) and galactooligosaccharide (GOS; Ingredion Incorporated, 
Indianapolis, IN, USA). Feed was prepared to contain 1.5 or 3% dietary inclusion levels 
of FOS or GOS replacing cellulose (Borrer, 1989). 
The effect of different organic acids at two dietary inclusion level also was 
evaluated. Sodium acetate (SA; sodium acetate Anhydrous, 99% H3CCOONa, BeanTown 
Chemical, Hudson, NH, USA), sodium lactate (SL; Sodium lactate 60 wt% in water 
C3H5NaO3, ACROS Organics, New Jersey, USA) and sodium propionate (SP; Sodium 
propionate 99% C3H5NaO2, Alfa Aesar, Tewksbury, MA, USA) were included in the 
diets for Litopenaeus vannamei at two different dietary inclusion levels (0.75 and 1.5%) 
replacing cellulose (Borrer, 1989).  
 
IV.2.5 Data acquisition and analyses 
All data was acquired and analyzed as described in Chapter II, Section II.2.5 for 
Trial I with the following exceptions:  
(1) No initial hemolymph sample was collected. 
(2) No biofloc sample was collected during the autotrophic phase for proximate 
composition. 
(3) Shrimp muscle was collected during the autotrophic phase for proximate 
composition. 
(4) Condition factor and hepatosomatic index were not evaluated. 
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(5) No initial sample or sample collected during the autotrophic phase was 
available for denaturing gradient gel electrophoresis of shrimp GT, HP or IC. 
IV.2.6 DNA isolation and PCR
DNA was isolated and PCR was conducted as previously described in Chapter II, 
section II.2.6 for Trial I. 
IV.2.7 Denaturing gradient gel electrophoresis
Denaturing gradient gel electrophoresis (DGGE) was performed as described for 
Trial I in Chapter II, Section II.2.7. 
IV.2.8 Calculations and statistical analyses
The responses utilized to compare treatments in this study as well as the statistical 
analyses were performed as described for Trial I in Chapter II, Section III.2.8. 
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IV.3 Results
Mean dissolved oxygen, water temperature, salinity and pH of the culture water 
are shown by treatment in Table IV.4. No differences (p ≤ 0.05) were observed in regard 
to shrimp final weight, weight gain, FE or survival when the prebiotics or the organic 
acid salts were added to the dietary treatments at any of the inclusion levels evaluated 
(Tables IV.5 and IV.6). A positive effect was observed on THC when organic acid salts 
were added to the feed of L vannamei (Table IV.6). Mean biofloc concentrations 
remained comparable with no differences (p ≤ 0.05) among any of the treatments 
evaluated in Trial III (Figures IV.1 and IV.2). 
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Table IV.4. Dissolved oxygen (mg/L), salinity (g/L), 
temperature (oC) and pH means from daily observations 
during Trial III.1
Treatment2 
Dissolved 
Oxygen 
(g/mL) 
Salinity 
(g/L) 
Temperature 
(oC) pH 
CTL 5.29 28.64 30.01 8.21 
FOS1.5 5.12 28.92 30.43 8.23 
FOS3.0 5.09 28.44 30.06 8.17 
GOS1.5 5.07 28.69 30.34 8.18 
GOS3.0 5.08 28.62 29.90 8.19 
SA0.75 5.09 28.87 30.41 8.21 
SA1.5 5.18 28.48 29.48 8.20 
SL0.75 5.28 28.62 29.79 8.20 
SL1.5 5.14 28.73 30.39 8.21 
SP0.75 5.15 28.23 29.96 8.19 
SP1.5 4.93 28.64 31.44 8.18 
PSE3 0.03 0.06 0.12 0.01 
1 Values represent treatment means. 
2 CTL = control reference; FOS1.5 = 1.5% fructooligosaccharide; 
FOS3.0 = 3% fructooligosaccharide; GOS1.5 = 1.5% 
galactooligosaccharide; GOS3.0 = 3% galactooligosaccharide; SA0.75 
= 0.75% sodium acetate; SA1.5 = 1.5% sodium acetate; SL0.75 = 
0.75% sodium lactate; SL1.5 = 1.5% sodium lactate; SP0.75 = 0.75% 
sodium propionate; SP1.5 = 1.5% sodium propionate. 
3 PSE = pooled standard error of treatment means (n = 3). 
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Table IV.5. Final weight, weight gain, feed efficiency and survival as 
well as THC of shrimp fed the control diet with no additive inclusion 
or the experimental diets with 1.5 or 3% dietary inclusion level of 
prebiotics fructooligosaccharide or galactooligosaccharide used for 
Trial III.1
Treatment2 
Final 
weight 
(g) 
Weight 
gain 
(%) FE 
Survival 
(%) THC 
CTL 8.4 212.9 1.47 91.23 1.43 
FOS1.5 8.0 204.7 1.57 91.23 1.90 
FOS3.0 7.6 209.2 1.81 94.74 1.97 
GOS1.5 8.0 224.5 1.39 94.74 1.89 
GOS3.0 9.1 229.1 1.34 87.72 2.17 
PSE3 0.29 5.76 0.11 1.84 0.14 
Anova 
(Pr > F) 
0.174 0.528 0.616 0.742 0.652 
1 Values represent treatment means. 
2 CTL = control reference; FOS1.5 = 1.5% fructooligosaccharide; FOS3.0 = 3% 
fructooligosaccharide; GOS1.5 = 1.5% galactooligosaccharide; GOS3.0 = 3% 
galactooligosaccharide; THC = total hemocyte count (106 cell/mL) 
3 PSE = pooled standard error of treatment means (n = 3). 
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Table IV.6. Final weight, weight gain, feed efficiency and survival as 
well as THC of shrimp fed the control diet with no additive inclusion 
or the experimental diets with 0.75 or 1.5% dietary inclusion level of 
organic acid salts sodium acetate, sodium lactate or sodium 
propionate used for Trial III.1
Treatment2 
Final 
weight g 
Weight 
gain % FE 
Survival 
% THC 
CTL 8.9 212.9 1.47 91.23 1.43
b 
SA0.75 7.4 199.5 1.70 94.74 2.18ab 
SA1.5 8.3 217.9 1.49 89.47 2.18ab 
SL0.75 8.1 222.3 1.40 94.74 2.50a 
SL1.5 7.7 220.9 1.39 100.00 2.54a 
SP0.75 7.7 225.3 1.40 98.24 1.80ab 
SP1.5 7.9 221.9 1.40 96.49 1.87ab 
PSE3 0.11 3.87 0.05 1.12 0.11 
Anova 
(Pr > F) 
0.175 0.687 0.597 0.120 0.033 
1 Values represent treatment means. 
2 CTL= control referenceSA0.75 = 0.75% sodium acetate; SA1.5 = 1.5% sodium 
acetate; SL0.75 = 0.75% sodium lactate; SL1.5 = 1.5% sodium lactate; SP0.75 = 
0.75% sodium propionate; SP1.5 = 1.5% sodium propionate; THC = total hemocyte 
count (107 cells/mL). 
3 PSE = pooled standard error of treatment means (n = 3). 
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Figure IV.1. Mean biofloc levels (mL/L) of tanks subjected to the dietary control 
treatment with no additive inclusion or the dietary experimental treatments with 1.5 or 
3.0% inclusion of prebiotics fructooligosaccharide or galactooligosaccharide during Trial 
III.1,2
1 Values are expressed as means with no significant differences (p ≤ 0.05) ± PSE (n = 3) of the weekly 
biofloc readings obtained from Imhoff cones. 
2 CTL = control reference; FOS1.5 = fructooligosaccharide at 1.5% dietary inclusion; FOS3.0 = 
fructooligosaccharide at 3% dietary inclusion; GOS1.5 = galactooligosaccharide at 1.5% dietary inclusion; 
GOS3.0 = galactooligosaccharide at 3.0% dietary inclusion. 
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Figure IV.2. Mean biofloc levels (mL/L) of tanks subjected to the dietary control 
treatment with no additive inclusion or the dietary experimental treatments with 0.75 or 
1.5% inclusion of organic acid salts sodium acetate, sodium propionate or sodium lactate 
during Trial III.1,2 
1 Values are expressed as means with no significant differences (p ≤ 0.05) ± PSE (n = 3) of the weekly 
biofloc readings obtained from Imhoff cones. 
2 CTL = control reference; SA0.75 = sodium acetate at 0.75% dietary inclusion; SA1.5 = sodium acetate at 
1.5% dietary inclusion; SL0.75 = sodium lactate at 0.75% dietary inclusion; SL1.5 = sodium lactate at 
1.5% dietary inclusion; SP0.75 = sodium propionate at 0.75% dietary inclusion; SP1.5 = sodium propionate 
at 1.5% dietary inclusion. 
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Total ammonia-nitrogen, nitrites, nitrates and alkalinity values showed no 
differences (p ≤ 0.05) among treatments in any of the observed responses for the 
treatments with prebiotics or organic acid salts included in the diet (Tables IV.7, IV.8, 
IV.9 and IV.10). No differences (p ≤ 0.05) were observed in the nutrient composition of
biofloc or shrimp muscle for any of the treatments evaluated in Trial III (Tables IV.11 
and IV.12). 
Table IV.7. Mean values over time for total-ammonia nitrogen (TAN) and nitrites 
of the dietary control treatment with no additive inclusion or the dietary 
experimental treatments with fructooligosaccharide or galactooligosaccharide at 
1.5 or 3% inclusion level used for Trial III.1 
Total Ammonia-Nitrogen Nitrites 
Treatment2 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
CTL 1.85 0.09 0.10 0.07 0.69 0.20 0.22 0.13 
FOS1.5 1.63 0.10 0.10 0.09 0.61 0.15 0.20 0.23 
FOS3.0 2.17 0.07 0.07 0.08 0.85 0.08 0.10 0.13 
GOS1.5 2.02 0.09 0.10 0.09 0.91 0.13 0.16 0.09 
GOS3.0 2.23 0.05 0.11 0.10 0.63 0.06 0.17 0.14 
PSE3 0.14 0.01 0.01 0.00 0.05 0.02 0.02 0.02 
Anova 
(Pr>F) 0.637 0.372 0.360 0.201 0.139 0.401 0.643 0.355 
1 Values represent treatment means of the weekly observations. 
2 CTL = control reference; FOS1.5 = fructooligosaccharide at 1.5% dietary inclusion; FOS3.0 = 
fructooligosaccharide at 3% dietary inclusion; GOS1.5 = galactooligosaccharide at 1.5% dietary 
inclusion; GOS3.0 = galactooligosaccharide at 3.0% dietary inclusion. 
3 PSE = pooled standard error of treatment means (n = 3). 
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Table IV.8. Mean values over time for nitrate and alkalinity of the dietary control 
treatment with no additive inclusion or the dietary experimental treatments with 
fructooligosaccharide or galactooligosaccharide at 1.5 or 3% inclusion level used for 
Trial III.1 
Nitrates Alkalinity 
Treatment2 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
CTL 5.57 18.78 22.41 29.49 167.0 153.3 156.3 180.0 
FOS1.5 5.75 18.16 28.28 25.52 176.7 154.0 143.0 232.0 
FOS3.0 6.43 14.93 17.98 23.10 188.3 157.3 147.7 193.7 
GOS1.5 4.48 15.33 17.35 23.71 170.0 151.0 150.3 180.7 
GOS3.0 3.74 13.72 16.81 20.37 175.3 144.0 144.0 166.3 
PSE3 0.56 0.88 1.57 1.90 3.37 2.82 3.15 11.75 
Anova 
(Pr>F) 
0.677 0.312 0.070 0.704 0.346 0.709 0.737 0.508 
1 Values represent treatment means of the weekly observations. 
2 CTL = control reference; FOS1.5 = fructooligosaccharide at 1.5% dietary inclusion; FOS3.0 = 
fructooligosaccharide at 3% dietary inclusion; GOS1.5 = galactooligosaccharide at 1.5% dietary 
inclusion; GOS3.0 = galactooligosaccharide at 3.0% dietary inclusion. 
3 PSE = pooled standard error of treatment means (n = 3). 
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Table IV.9. Mean values over time for total-ammonia nitrogen (TAN) and nitrites of 
the dietary control treatment with no additive inclusion or the dietary experimental 
treatments with sodium acetate, sodium lactate or sodium propionate at 0.75 or 1.5% 
inclusion level used for Trial III.1 
Total Ammonia-Nitrogen Nitrites 
Treatment2 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
CTL 1.85 0.09 0.10 0.07 0.69 0.20 0.22 0.13 
SA0.75 1.92 0.08 0.11 0.15 0.70 0.08 0.12 0.44 
SA1.5 2.23 0.08 0.11 0.12 0.70 0.07 0.17 0.15 
SL0.75 2.27 0.10 0.09 0.09 0.94 0.10 0.16 0.29 
SL1.5 1.69 0.08 0.11 0.10 0.64 0.12 0.20 0.22 
SP0.75 1.77 0.08 0.10 0.14 0.46 0.14 0.18 0.24 
SP1.5 1.61 0.11 0.12 0.07 0.76 0.21 0.27 0.16 
PSE3 0.10 0.01 0.01 0.01 0.06 0.02 0.02 0.03 
Anova 
(Pr>F) 
0.449 0.532 0.964 0.578 0.532 0.325 0.653 0.093 
1 Values represent treatment means of the weekly observations. 
2 CTL = control reference; SA0.75 = sodium acetate at 0.75% dietary inclusion; SA1.5 = sodium 
acetate at 1.5% dietary inclusion; SL0.75 = sodium lactate at 0.75% dietary inclusion; SL1.5 = sodium 
lactate at 1.5% dietary inclusion; SP0.75 = sodium propionate at 0.75% dietary inclusion; SP1.5 = 
sodium propionate at 1.5% dietary inclusion. 
3 PSE = pooled standard error of treatment means (n = 3). 
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Table IV.10. Mean values over time for nitrates and alkalinity of the dietary control 
treatment with no additive inclusion or the dietary experimental treatments with sodium 
acetate, sodium lactate or sodium propionate at 0.75 or 1.5% inclusion level used for Trial 
III.1 
Nitrates Alkalinity 
Treatment2 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
Day 
1 
Day 
8 
Day 
15 
Day 
22 
CTL 5.57 18.78 22.41 29.49 167.0 153.3 156.3 180.0 
SA0.75 5.06 17.88 32.10 22.76 170.3 145.7 156.0 189.0 
SA1.5 4.11 15.29 22.71 23.07 169.3 149.0 156.3 168.3 
SL0.75 8.76 17.20 20.31 25.56 165.7 154.3 155.3 152.0 
SL1.5 5.66 15.91 20.31 27.28 197.7 148.0 153.7 169.0 
SP0.75 4.52 15.64 16.71 19.43 174.0 144.3 147.0 170.7 
SP1.5 4.97 16.99 16.82 27.48 176.0 155.7 164.7 212.0 
SPE3 0.67 0.83 1.88 1.56 3.56 2.09 3.60 8.16 
Anova 
(Pr>F) 
0.67
7 
0.947 0.389 0.714 0.224 0.759 0.961 0.646 
1 Values represent treatment means of the weekly observations. 
2 CTL = control reference; SA0.75 = sodium acetate at 0.75% dietary inclusion; SA1.5 = sodium 
acetate at 1.5% dietary inclusion; SL0.75 = sodium lactate at 0.75% dietary inclusion; SL1.5 = sodium 
lactate at 1.5% dietary inclusion; SP0.75 = sodium propionate at 0.75% dietary inclusion; SP1.5 = 
sodium propionate at 1.5% dietary inclusion. 
3 PSE = pooled standard error of treatment means (n = 3). 
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Table IV.11. Ash, protein and lipid content of biofloc and muscle 
of shrimp fed the control diet with no additive inclusion or the 
experimental diets with prebiotics fructooligosaccharide or 
galactooligosaccharide at 1.5 or 3.0% dietary inclusion levels 
used for Trial III.1,4 
Biofloc Muscle 
Treatment2 Ash Protein Lipids Ash Protein Lipids 
ATr 5.8 82.8 14.5 
CTL 80.0 5.0 3.2 6.1 85.4 15.4 
FOS1.5 80.2 4.0 6.1 6.2 85.2 14.5 
FOS3.0 82.0 4.3 5.0 6.1 82.1 14.7 
GOS1.5 81.7 3.6 2.9 6.1 85.5 15.4 
GOS3.0 80.0 4.9 6.7 6.2 84.4 15.8 
PSE3 0.55 0.26 0.56 0.11 0.62 0.29 
Anova 
(Pr>F) 
0.706 0.449 0.101 0.854 0.535 0.741 
1 Values represent treatment means. 
2 CTL = control reference; FOS1.5 = fructooligosaccharide at 1.5% dietary 
inclusion; FOS3.0 = fructooligosaccharide at 3% dietary inclusion; GOS1.5 = 
galactooligosaccharide at 1.5% dietary inclusion; GOS3.0 = 
galactooligosaccharide at 3.0% dietary inclusion. 
3 PSE = pooled standard error of treatment means (n = 3). 
4 Proximate composition analyses of ash and lipids were performed with no 
duplicate sample because not enough sample was available. 
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Table IV.12. Ash, protein and lipid content of biofloc and muscle 
of shrimp fed the control diet with no additive inclusion or the 
experimental diets with sodium acetate, sodium lactate or sodium 
propionate at 0.75 or 1.5% dietary inclusion levels used for Trial 
III.1,4
Biofloc Muscle 
Treatment2 Ash Protein Lipids Ash Protein Lipids 
ATr 5.8 82.8 14.5 
CTL 80.0 5.0 3.3 6.1 85.4 15.4 
SA0.75 78.9 4.3 4.3 6.7 86.4 16.2 
SA1.5 78.5 5.1 5.4 6.0 84.1 15.5 
SL0.75 82.2 4.0 5.5 6.7 84.1 15.5 
SL1.5 82.2 3.5 5.0 6.9 87.0 12.9 
SP0.75 82.8 3.4 4.5 6.2 85.0 15.7 
SP1.5 81.3 3.8 4.7 6.3 84.2 15.1 
PSE3 0.57 0.23 0.39 0.12 0.46 0.29 
Anova 
(Pr>F) 
0.260 0.265 0.846 0.174 0.318 0.182 
1 Values represent treatment means. 
2 CTL = control reference; SA0.75 = sodium acetate at 0.75% dietary 
inclusion; SA1.5 = sodium acetate at 1.5% dietary inclusion; SL0.75 = 
sodium lactate at 0.75% dietary inclusion; SL1.5 = sodium lactate at 1.5% 
dietary inclusion; SP0.75 = sodium propionate at 0.75% dietary inclusion; 
SP1.5 = sodium propionate at 1.5% dietary inclusion. 
3 PSE = pooled standard error of treatment means (n = 3). 
4 Proximate composition analyses of ash and lipids were performed with no 
duplicate sample because not enough sample was available. 
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Bacterial communities present in biofloc (Figure IV.3) for the GOS1.5, GOS3.0, 
SA0.75, FOS1.5, FOS1.5 and SL0.75 treatments were likely the same or identical and 
they were very similar to SL0.75, SL0.75, SA1.5 and CTL. The bacterial community 
present in the SP1.5 is similar to communities for all other treatments. Bacterial 
communities present in ATr and SP0.75 were likely the same or identical and they were 
similar to those in biofloc from the other treatments. 
Bacterial communities present in the gills tissue (Figure IV.4) for the SL1.5 and 
SP1.5 treatments were somewhat similar to each other but not similar to those for the 
remaining treatments. Communities of the CTL, SL0.75 and FOS1.5 treatments were 
very similar to each other and only similar to the ATr, SA0.75, SP0.75, SA1.5, FOS3.0, 
GOS1.5 and GOS3.0 treatments. The bacterial community of the ATr phase was likely 
the same or identical to the bacterial community of the SA0.75 and both were very 
similar to the bacterial community of the SP0.75 treatment. Bacterial communities of the 
ATr, SA0.75 and SP0.75 were similar to the bacterial communities present in the SA1.5, 
FOS3.0, GOS1.5 and GOS3.0 treatments. In addition, the bacterial communities of the 
SA1.5 and FOS3.0 treatments were very similar to each other and to the bacterial 
communities of GOS1.5 and GOS3.0. Bacterial communities present in the GOS1.5 and 
GOS3.0 treatments were likely the same or identical. 
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Figure IV.3. Dendrogram of the biofloc particles (BFP) bacterial communities collected during the autotrophic phase (ATr) or 
during termination from the tanks subjected to the control dietary treatment with no additive inclusion (CTL) or to the 
experimental treatments with 1.5 or 3.0% dietary inclusion of fructooligosaccharide (FOS) or galactooligosaccharide (GOS) or 
0.75 or 1.5% dietary inclusion of sodium acetate (SA), sodium lactate (SL) or sodium propionate (SP) of Trial III. 
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Figure IV.4. Dendrogram of the gills tissue (GT) bacterial communities collected during the autotrophic phase (ATr) or during 
termination from the tanks subjected to the control dietary treatment with no additive inclusion (CTL) or to the experimental 
treatments with 1.5 or 3.0% dietary inclusion of fructooligosaccharide (FOS) or galactooligosaccharide (GOS) or 0.75 or 1.5% 
dietary inclusion of sodium acetate (SA), sodium lactate (SL) or sodium propionate (SP) of Trial III. 
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Hepatopancreas bacterial communities (Figure IV.5) for the SP0.75, SL1.5 and 
SA1.5 treatments were not similar to each other and to the other treatments. The bacterial 
community present during the ATr phase was somewhat similar to the bacterial 
communities present in the SA0.75, SL0.75, GOS1.5, CTL, FOS1.5, GOS3.0, FOS3.0 
and SP0.75 treatments. In addition, those communities for the SA0.75 and SL0.75 
treatments were similar to each other and they were similar to the GOS1.5, CTL, FOS1.5, 
GOS3.0, FOS3.0 and SP1.5 treatments. Bacterial communities present in the GOS1.5, 
CTL, FOS1.5, GOS3.0 and FOS3.0 treatments are very similar. 
Intestinal contents bacterial communities (Figure IV.6) for the FOS1.5 and 
SL0.75 treatments were very similar to each other, somewhat similar to the CTL 
treatment and not similar to those of the remaining treatments. Bacterial community of 
the FOS3.0 treatment was not similar to communities of other treatments. In addition, 
bacterial communities of the SP0.75, GOS3.0, SA1.5, SA0.75 and GOS1.5 treatments 
were very similar to each other, similar to SP0.75, and somewhat similar to ATr and 
SL0.75. The SP1.5 treatment community was somewhat similar to the bacterial 
communities of the ATr and SL0.75 treatments. Also, the bacterial communities of the 
SL0.75 and ATr treatments were somewhat similar. 
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Figure IV.5. Dendrogram of the hepatopancreas (HP) bacterial communities collected during the autotrophic phase (ATr) or 
during termination from the tanks subjected to the control dietary treatment with no additive inclusion (CTL) or to the 
experimental treatments with 1.5 or 3.0% dietary inclusion of fructooligosaccharide (FOS) or galactooligosaccharide (GOS) or 
0.75 or 1.5% dietary inclusion of sodium acetate (SA), sodium lactate (SL) or sodium propionate (SP) of Trial III. 
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Figure IV.6. Dendrogram of the intestinal contents (IC) bacterial communities collected during the autotrophic phase (ATr) or 
during termination from the tanks subjected to the control dietary treatment with no additive inclusion (CTL) or to the 
experimental treatments with 1.5 or 3.0% dietary inclusion of fructooligosaccharide (FOS) or galactooligosaccharide (GOS) or 
0.75 or 1.5% dietary inclusion of sodium acetate (SA), sodium lactate (SL) or sodium propionate (SP) of Trial III.
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Analysis of the bacterial communities present in the different tissues for the ATr 
treatment (Figure IV.7) showed that communities present in the GT and IC were similar 
but not similar to the communities in the BFP and HP. The bacterial community in the 
BFP was not similar to the bacterial community of the HP. 
Analysis of the bacterial communities present in the different tissues for the CTL 
treatment (Figure IV.8) showed that the HP community was somewhat similar to the IC 
community but they were not similar to the communities present in the BFP and GT. 
Bacterial communities present in the BFP were not similar to the bacterial communities 
present in the GT. 
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Figure IV.7. Dendrogram of the bacterial communities present in the biofloc particles (BFP), and shrimp gills tissue (GT), 
hepatopancreas (HP) and intestinal contents (IC) collected during the autotrophic phase (ATr) of Trial III. 
Figure IV.8. Dendrogram of the bacterial communities present in the biofloc particles (BFP), and shrimp gills tissue (GT), 
hepatopancreas (HP) and intestinal contents (IC) collected during termination from tanks subjected to the control dietary 
treatment with no additive inclusion (CTL) of Trial III. 
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IV.4 Discussion
The effects of the prebiotics FOS and GOS included in the diet of L. vannamei at 
3 or 1.5% levels replacing cellulose and/or diatomaceous earth were evaluated in Trial 
III. In addition, the effect of the organic acid salts SA, SL and SP included in the
experimental diets for L. vannamei at 0.75 and 1.5% dietary inclusion levels replacing 
diatomaceous earth was also evaluated. The variation in fiber was not expected to 
produce an effect on nutrient digestibility, growth or survival of L. vannamei (Borrer, 
1989). 
In spite there being no water exchange throughout the experiment, all water 
quality parameters were within safe limits for shrimp culture (Ebeling et al., 2006; 
Wasielesky et al., 2006). In particular, alkalinity was lower than the target and a dramatic 
reduction in ammonia and nitrites occurred during second and third week. This indicates 
that the nitrification process occurred in all tanks at a high rate because, during 
nitrification, chemoautotrophs consume carbon (CO2 or HCO3) for energy and produce 
hydrogen ions (H+) which reduces the alkalinity in the water (Ebeling et al., 2006). Total 
ammonia-nitrogen, nitrites, nitrates and alkalinity readings had no significant differences 
among treatments in any of the observations for treatments with prebiotics or organic 
acid salts inclusion in the diet. This result showed that the switch to a lower protein 
content diet increased the C:N ratio enough to promote the heterotrophic bacteria 
dominance and drastically reduced the toxic nitrogen waste compounds. 
No significant differences (p ≤ 0.05) were observed in nutrient composition of 
biofloc or shrimp muscle from any of the treatments evaluated in Trial III. Although 
some studies have reported that the reduction in protein content of diets does not affect 
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growth in shrimp cultured under biofloc conditions, in part because shrimp supplement 
their protein requirements with the protein provided by biofloc (Wasielesky et al. 2006; 
Ballester et al. 2010; Xu et al., 2012). For this particular experiment, the protein 
contribution from biofloc was lower than expected. No higher protein content diet was 
fed during the heterotrophic phase of the experiment. Possibly, the results found here 
indicate that, for the particular conditions in which this experiment was performed, the 
system could tolerate a higher protein content diet to promote a higher shrimp growth rate 
without compromising water quality and shrimp survival. 
No significant differences (p ≤ 0.05) were observed in final weight, weight gain, 
FE or survival of any of the treatments evaluated on Trial III, which is in agreement with 
other studies using prebiotics without an effect on growth or survival of L. vannamei (Li 
et al., 2007; Luna-Gonzalez et al., 2012). However, a positive effect (p ≤ 0.05) was 
observed on THC when organic acid salts were added to the feed. The important role 
hemocytes play in antibacterial activity of crustaceans has been well described (Chisholm 
and Smith, 1995). Although the THC varies among different crustacean species and is 
known to be affected by a variety of factors, such as culture conditions, infection and 
environmental stress, the THC of circulating hemocytes correlates well with the health 
condition of shrimp and its ability to resist pathogens (Le Moullac et al., 1998; Le 
Moullac and Hanner, 2000). The increase in THC of shrimp fed diets containing organic 
acid salts is an encouraging result that needs to be evaluated in shrimp subjected to a 
stressor or a disease challenge to confirm an enhancement in shrimp production 
performance. 
107 
Mean biofloc concentrations remained with no differences among any of the 
treatments evaluated in Trial III (Figures 12 and 13). This result was also observed in 
Trial II. These is the first study that evaluated the biofloc level of a shrimp culture when 
prebiotics or organic acid salts were included in the diet. Apparently, modifications in the 
diet and, more specifically, prebiotics or organic acid salts dietary inclusion, does not 
affect biofloc concentration in the culture tanks as much as the inclusion of additives 
directly to the culture water (Figure 1). However, these results need to be confirmed with 
more evaluations in order to determine the best route of entry of additives to maintain 
BFT system under optimal conditions. 
Some effects on the bacterial communities of BP, GT, HP and IC were observed 
in all the dietary treatments evaluated in this study. Similar effects were observed in Trial 
I and II and are in agreement with other studies evaluating bacterial community changes 
when additives are included in the diet of different aquatic species (Ringo et al., 2006; 
Mahious et al., 2006; Bakke-Mckellep et al., 2007). 
Further studies are needed to identify bacterial species and to determine if disease 
resistance and growth is increased in challenged organisms. 
In conclusion, data presented in this study confirms the following: 
(1) An effect on bacterial communities of biofloc particles and shrimp gills, 
hepatopancreas and intestinal contents were observed when prebiotics were added to the 
feed. 
(2) The inclusion of organic acid salts into the shrimp diet also altered the 
bacterial composition of biofloc particles and shrimp gills, hepatopancreas and intestinal 
contents. 
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(3) A positive effect on the total hemocyte counts of shrimp fed the diets 
containing different organic acid salts indicates an improvement in shrimp health and a 
potential higher resistance to pathogens. 
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CHAPTER V 
CONCLUSIONS 
This dissertation compiled results from three trials performed to determine the 
effect of prebiotics, organic acid salts and a commercially available essential oil blend on 
bacterial composition of biofloc particles and shrimp gills, hepatopancreas and intestinal 
contents as well as on shrimp health and production performance of shrimp cultured 
under Biofloc Technology (BFT) conditions. 
Denaturing gradient gel electrophoresis (DGGE) results obtained in the three 
trials demonstrated that the bacterial flora of biofloc and the cultured organisms may be 
affected by the type of additive used, regardless of if it is added to the feed or to the 
culture water. These results also demonstrate that the bacterial community composition 
present during the autotrophic phase was modified when a heterotrophic dominance was 
promoted. Shrimp and biofloc bacterial flora did not change much from the autotrophic 
(ATr) phase with the addition of wheat starch (WSt) because it is a complex carbohydrate 
that is not easily utilized by microbes. 
In general, a difference in bacterial population was observed when prebiotics, 
organic acid salts or the essential oil blend were included in the diet or added directly to 
the culture water. Additives included in the feed have the capability to change bacterial 
communities present in biofloc particles and cultured organism’s tissues and organs. 
Bacterial communities present in the WSt and control (CTL) treatment and collected 
during the ATr phase were generally the most similar compared to each other but they 
differ to the rest of the treatments, indicating that prebiotics, organic acid salts and the 
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essential oil blend (EOB) promoted the proliferation of different bacterial species in the 
culture system and in cultured organism’s internal and external tissues and organs. 
Special interest for shrimp culture is the analysis of the bacterial populations of 
different tissues. In Trial II and III, differences were observed in bacterial composition of 
different tissues and organs which means that shrimp are able to maintain certain species 
of bacteria in some locations and avoid others to enter. The difference in bacterial 
composition could be related to the different functions and environments of the organs or 
tissues sampled. Also, the relation between the bacterial epiflora present in gills and their 
nutrient uptake from dissolved organic matter could explain the difference in bacterial 
populations of the gills when compared to those of the biofloc, hepatopancreas and 
intestinal contents. 
The health parameter evaluated in these studies was the total hemocyte count 
(THC). A positive effect was observed on the THC when shrimp were fed diets 
containing the EOB and the organic acid salts. However, this positive effect was not 
reflected in production data. It has to be noted that no health challenge (viral,, 
environmental, bacterial or chemical) was performed in any of the trials so, possibly, the 
difference in bacterial composition along with the increase in the THC, could have a 
positive effect on shrimp performance parameters when shrimp health is compromised. 
The lack of an effect on weight gain or survivability was likely because shrimp 
had no external source of stress and shrimp had a low growth rate possibly related to 
underfeeding. However, this must not overshadow the importance of observing changes 
in bacterial communities and the increase on the THC promoted by the additives used in 
these studies. 
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Further research is warranted on the positive effect that the prebiotics, organic 
acid salts and the EOB may confer to shrimp production by altering the bacterial 
communities and increasing the THC when a source of stress is induced to the culture 
organisms and with organisms with a higher growth rate. Furthermore, identification of 
the bacterial flora present in biofloc and shrimp gills, hepatopancreas and intestinal 
contents when prebiotics, organic acid salts and essential oils are incorporated into the 
diet or added directly into the culture water, should yield more information on the 
advantages of using these additives in shrimp aquaculture. 
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APPENDIX 
Vitamin/Mineral Premix Ingredient Levels 
Ingredient Level Ingredient Level 
Calcium (%) 0.16 D-Pantothenic (mg/kg) 2,975.06 
Total Phosphorus (%) 0.43 Riboflavin (mg/kg) 1,342.40 
Av. Phosphorus (%) 18.48 Thiamine (mg/kg) 1,668.93 
Ca:Pav 0.01 Vitamin B-6 (mg/kg) 1,995.46 
Salt (%) 0.22 Vitamin B-12 (mcg/kg) 834.47 
Sodium (%) 0.11 Vitamin C (mg/kg) 8,272.11 
Chloride (%) 0.11 Copper (mg/kg) 2,185.00 
Potassium (%) 0.44 Iron (mg/kg) 138.30 
Magnesium (%) 0.18 Manganese (mg/kg) 1,013.00 
Vitamin A (KIU/kg) 199.55 Zinc (mg/kg) 2,185.00 
Vitamin D (KIU/kg) 83.45 Cobalt (mg/kg) 1.30 
Vitamin E (IU/kg) 4,970.52 Sulfur (%) 0.19 
Vitamin K (mg/kg) 1,015.87 Copper (organic) (mg/kg) 2,185.00 
Biotin (mcg/kg) 32,979.60 Manganese (organic) (mg/kg) 1,010.00 
Folic acid (mg/kg) 330.16 Zinc (organic) (mg/kg) 2,185.00 
Niacin (mg/kg) 4,136.05 
